Elizabeth Arden (RDEN) 10-Q 6 Feb 15 2015 Q2 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	6 Months Ended
	Dec. 31, 2014	Feb. 03, 2015
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q2
Entity Registrant Name	ELIZABETH ARDEN INC
Entity Central Index Key	95052
Current Fiscal Year End Date	-24
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		29,811,655

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Current Assets
Cash and cash equivalents	$94,144	$56,308
Accounts receivable, net	188,380	160,806
Inventories	288,320	338,826
Deferred income taxes	2,198	3,742
Prepaid expenses and other assets	38,477	48,076
Total current assets	611,519	607,758
Property and equipment, net	111,357	116,806
Exclusive brand licenses, trademarks and intangibles, net	229,644	275,004
Goodwill	31,607	31,607
Debt financing costs, net	8,103	7,225
Deferred income taxes	5,431	5,213
Other	13,562	18,040
Total assets	1,011,223	1,061,653
Current Liabilities
Short-term debt	58,900	80,418
Accounts payable - trade	84,307	81,660
Other payables and accrued expenses	122,799	111,953
Total current liabilities	266,006	274,031
Long-term Liabilities
Long-term debt	356,033	356,432
Deferred income taxes and other liabilities	55,755	54,648
Total long-term liabilities	411,788	411,080
Total liabilities	677,794	685,111
Redeemable noncontrolling interest (See Note 5)	4,638	5,553
Commitments and contingencies (See Note 11)
Redeemable Series A Serial Preferred Stock, $0.01 par value 50,000 shares authorized: 50,000 shares issued and outstanding	50,000
Shareholders' Equity
Common stock, $.01 par value, 50,000,000 shares authorized; 34,652,963 and 34,599,106 shares issued, respectively	346	346
Additional paid-in capital	372,848	356,260
Retained earnings	9,763	112,337
Treasury stock (4,841,308 shares at cost)	-93,169	-93,169
Accumulated other comprehensive loss	-10,997	-4,785
Total shareholders' equity	278,791	370,989
Total liabilities, redeemable noncontrolling interest, redeemable preferred stock and shareholders' equity	$1,011,223	$1,061,653

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Jun. 30, 2014
Consolidated Balance Sheets [Abstract]
Preferred stock, par value	$0.01
Preferred stock, shares authorized	50,000
Preferred stock, shares issued	50,000
Preferred stock, shares outstanding	50,000
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	34,652,963	34,599,106
Treasury stock, shares at cost	4,841,308	4,841,308

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements Of Operations [Abstract]
Net sales	$333,607	$418,137	$603,985	$761,746
Cost of goods sold:
Cost of sales	188,762	225,236	350,088	418,910
Depreciation related to cost of goods sold	1,960	1,987	3,959	3,817
Total cost of goods sold	190,722	227,223	354,047	422,727
Gross profit	142,885	190,914	249,938	339,019
Operating expenses:
Selling, general and administrative	180,205	129,003	294,070	258,375
Depreciation and amortization	10,795	11,137	21,508	21,836
Total operating expenses	191,000	140,140	315,578	280,211
(Loss) income from operations	-48,115	50,774	-65,640	58,808
Other expense
Interest expense, net	7,712	5,734	15,468	11,766
Debt Extinguishment charges	239		239
Other expense, net	7,951	5,734	15,707	11,766
(Loss) income before income taxes	-56,066	45,040	-81,347	47,042
Provision for income taxes	833	10,384	1,057	10,798
Net (loss) income	-56,899	34,656	-82,404	36,244
Net loss attributable to noncontrolling interests (See Note 5)	-760	-297	-915	-406
Net (loss) income attributable to Elizabeth Arden shareholders	-56,139	34,953	-81,489	36,650
Less: Accretion and dividends on preferred stock (See Note 12)	639		21,085
Net (loss) income attributable to Elizabeth Arden common shareholders	($56,778)	$34,953	($102,574)	$36,650
Net (loss) income per common share attributable to Elizabeth Arden shareholders:
Basic	($1.90)	$1.18	($3.44)	$1.24
Diluted	($1.90)	$1.16	($3.44)	$1.21
Weighted average number of common shares:
Basic	29,812	29,649	29,796	29,648
Diluted	29,812	30,129	29,796	30,182

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive (Loss) Income (USD $)	3 Months Ended				6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2014		Dec. 31, 2013
Consolidated Statements Of Comprehensive (Loss) Income [Abstract]
Net (loss) income	($56,899)		$34,656		($82,404)		$36,244
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	-3,230	[1]	-2,086	[1]	-9,517	[1]	107	[1]
Net unrealized cash flow hedging (loss) gain	-23	[2]	-540	[2]	3,305	[2]	-1,907	[2]
Total other comprehensive loss, net of tax	-3,253		-2,626		-6,212		-1,800
Comprehensive (loss) income	-60,152		32,030		-88,616		34,444
Net loss attributable to noncontrolling interests	-760		-297		-915		-406
Comprehensive (loss) income attributable to Elizabeth Arden shareholders	-59,392		32,327		-87,701		34,850
Net unrealized cash flow hedging gain (loss), tax expense (benefit)	$145		$125		$623		($64)
[1]	Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.
[2]	Net of tax expense of $145 and $125 for the three months ended December 31, 2014 and 2013, respectively. Net of tax expense of $623 for the six months ended December 31, 2014, and net of tax benefit of $64 for the six months ended December 31, 2013.

Consolidated_Statement_Of_Shar

Consolidated Statement Of Shareholders' Equity (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Share data in Thousands
Balance at Jun. 30, 2014	$346,000	$356,260,000	$112,337,000	($93,169,000)	($4,785,000)	$370,989,000
Balance, shares at Jun. 30, 2014	34,599			-4,841
Issuance of restricted stock, net of forfeitures and tax withholdings		-384,000				-384,000
Issuance of restricted stock, net of forfeitures and tax withholdings, shares	54
Amortization of share-based awards		2,674,000				2,674,000
Issuance of warrants to purchase common stock		14,144,000				14,144,000
Excess tax benefit from share-based awards		154,000				154,000
Net loss attributable to Elizabeth Arden shareholders			-81,489,000			-81,489,000
Preferred stock accretion to redemption value			-20,151,000			-20,151,000
Preferred stock dividends			-934,000			-934,000
Foreign currency translation adjustments					-9,517,000	-9,517,000	[1]
Net unrealized cash flow hedging gain					3,305,000	3,305,000	[2]
Balance at Dec. 31, 2014	$346,000	$372,848,000	$9,763,000	($93,169,000)	($10,997,000)	$278,791,000
Balance, shares at Dec. 31, 2014	34,653			-4,841
[1]	Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.
[2]	Net of tax expense of $145 and $125 for the three months ended December 31, 2014 and 2013, respectively. Net of tax expense of $623 for the six months ended December 31, 2014, and net of tax benefit of $64 for the six months ended December 31, 2013.

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Operating Activities:
Net (loss) income	($82,404)	$36,244
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	25,467	25,653
Asset impairments	42,931
Amortization of senior note offering and credit facility costs	842	685
Amortization of senior note premium	-399
Amortization of share-based awards	2,674	3,225
Debt Extinguishment charges	239
Deferred income taxes	344	6,258
Change in assets and liabilities, net of acquisitions:
Increase in accounts receivable	-32,815	-61,606
Decrease (increase) in inventories	46,858	-32,074
Decrease (increase) in prepaid expenses and other assets	10,431	-6,400
Increase in accounts payable	5,010	30,810
Increase in other payables, accrued expenses and other liabilities	17,727	12,206
Other	231	232
Net cash provided by operating activities	37,136	15,233
Investing Activities:
Additions to property and equipment	-14,608	-25,822
Acquisition of businesses, intangibles and other assets	-2,300	-3,000
Cash received from consolidation of variable interest entity		574
Net cash used in investing activities	-16,908	-28,248
Financing Activities:
(Payments on) proceeds from short-term debt	-21,518	7,750
Proceeds from the issuance of preferred stock and warrants, net of issuance costs	43,993
Proceeds from the exercise of stock options		1,758
Financing fees paid	-1,947
Preferred stock dividend	-147
Repurchase of common stock		-5,393
Proceeds from the issuance of common stock under the employee stock purchase plan		1,101
Payments of contingent consideration related to acquisition		-4,914
Payments to noncontrolling interests		-4,979
Payments under capital lease obligations	-59	-35
Net cash provided by (used in) financing activities	20,322	-4,712
Effect of exchange rate changes on cash and cash equivalents	-2,714	-53
Net increase (decrease) in cash and cash equivalents	37,836	-17,780
Cash and cash equivalents at beginning of period	56,308	61,674
Cash and cash equivalents at end of period	94,144	43,894
Supplemental Disclosure of Non-Cash Information:
Additions to property and equipment not paid for (not included above)	1,536	2,338
Accretion on preferred stock (not included above)	20,151
Dividends on preferred stock not paid for (not included above)	$786

Business_And_Basis_Of_Presenta

Business And Basis Of Presentation	6 Months Ended
	Dec. 31, 2014
Business And Basis Of Presentation [Abstract]
Business And Basis Of Presentation	NOTE 1. BUSINESS AND BASIS OF PRESENTATION
	Elizabeth Arden, Inc. (the "Company" or "our") is a global prestige beauty products company that sells fragrances, skin care and cosmetic products to retailers in the United States and approximately 120 countries internationally.
	The unaudited consolidated financial statements include the accounts of the Company's wholly-owned domestic and international subsidiaries, as well as a variable interest entity ("VIE") of which the Company is the primary beneficiary in accordance with consolidation accounting guidance. See Note 5 for information on the consolidated VIE. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "Commission") for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statement presentation and should be read in conjunction with the audited consolidated financial statements and related footnotes included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2014 (the "2014 Annual Report"), filed with the Commission.
	The consolidated balance sheet of the Company as of June 30, 2014, is derived from the financial statements included in the 2014 Annual Report but does not include all disclosures required by accounting principles generally accepted in the United States. The other consolidated financial statements presented in this quarterly report are unaudited but include all adjustments that are of a normal recurring nature that management considers necessary for the fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of results for the full fiscal year.
	During the second quarter of fiscal 2015, the Company revised its forecast for its Canadian affiliate which is now projected to show a loss for fiscal 2015, in part due to the impact of our 2014 Performance Improvement Plan described in Note 4 and to foreign exchange losses resulting from large fluctuations in currency conversion rates. Based on the projected cumulative taxable loss for the three fiscal years ending June 30, 2015, as well as the Companys consideration of the weight of positive and negative evidence, the Company recorded a total valuation allowance of $2.5 million against its Canadian deferred tax assets as a non-cash charge to income tax expense of which $2.1 million was recorded on a discrete basis.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	6 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	NOTE 2. ACCUMULATED OTHER COMPREHENSIVE LOSS
	The Company's accumulated other comprehensive loss shown on the accompanying consolidated balance sheets consists of foreign currency translation adjustments, which are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries, and the unrealized gains (losses), net of taxes, related to the Company's foreign currency contracts.
	The components of accumulated other comprehensive loss were as follows:
			December 31,			June 30,
	(Amounts in thousands)		2014			2014
	Cumulative foreign currency translation adjustments	$	(12,139	)	$	(2,622	)
	Unrealized hedging gains (losses), net of taxes (1)		1,142			(2,163	)
	Accumulated other comprehensive loss	$	(10,997	)	$	(4,785	)
	(1) Net of tax expense of $265 as of December 31, 2014 and net of tax benefit of $359 as of June 30, 2014.

Net_Loss_Income_Per_Share_Attr

Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders	6 Months Ended
	Dec. 31, 2014
Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders [Abstract]
Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders	NOTE 3. NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO ELIZABETH ARDEN COMMON SHAREHOLDERS
	Basic net (loss) income per share attributable to Elizabeth Arden Common Stock shareholders is computed by dividing the net (loss) income attributable to Elizabeth Arden common shareholders by the weighted average shares of the Company's outstanding common stock, $.01 par value per share (Common Stock). The calculation of net (loss) income attributable to Elizabeth Arden common shareholders per diluted share is similar to basic net (loss) income per share attributable to Elizabeth Arden common shareholders except that the denominator includes potentially dilutive Common Stock, such as stock options, non-vested restricted stock and restricted stock units, and warrants. For the three and six months ended December 31, 2014, diluted net loss per share equals basic net loss per share as the assumed exercise of stock options, non-vested restricted stock units, and warrants would have an anti-dilutive effect.
	The following table represents the computation of net (loss) income per share attributable to Elizabeth Arden common shareholders:
	(Amounts in thousands, except per
	share data)		Three Months Ended					Six Months Ended
			December 31,			December 31,		December 31,			December 31,
			2014			2013		2014			2013
	Basic
	Net (loss) income attributable to Elizabeth
	Arden common shareholders	$	(56,778	)	$	34,953	$	(102,574	)	$	36,650
	Weighted average shares outstanding		29,812			29,649		29,796			29,648
	Net (loss) income per basic share
	attributable
	to Elizabeth Arden common
	shareholders	$	(1.90	)	$	1.18	$	(3.44	)	$	1.24
	Diluted
	Net (loss) income attributable to Elizabeth
	Arden common shareholders	$	(56,778	)	$	34,953	$	(102,574	)	$	36,650
	Weighted average shares outstanding		29,812			29,649		29,796			29,648
	Potential common shares - treasury
	method		--			480		--			534
	Weighted average shares and potential
	dilutive common shares		29,812			30,129		29,796			30,182
	Net (loss) income per diluted share
	attributable to Elizabeth Arden common
	shareholders	$	(1.90	)	$	1.16	$	(3.44	)	$	1.21
	The following table shows the number of l common stock equivalents for the three and six months ended December 31, 2014 and 2013 that were not included in the net (loss) income per diluted share attributable to Elizabeth Arden common shareholders calculation because to do so would have been anti-dilutive:
	(Amounts in thousands)	Three Months Ended		Six Months Ended
		December 31,	December 31,	December 31,	December 31,
		2014	2013	2014	2013
	Number of shares	3,276	104	3,276	81

2014_Performance_Improvement_P

2014 Performance Improvement Plan And Other Restructuring	6 Months Ended
	Dec. 31, 2014
2014 Performance Improvement Plan And Other Restructuring [Abstract]
2014 Performance Improvement Plan And Other Restructuring	NOTE 4. 2014 PERFORMANCE IMPROVEMENT PLAN AND OTHER RESTRUCTURING
	The 2014 Performance Improvement Plan, approved by the Board of Directors on June 23, 2014, includes the exiting of certain unprofitable retail doors and fragrance license agreements, changes in customer, distribution and supply chain relationships, the discontinuation of certain products, the elimination of approximately 175 employee positions globally, and the closing of the Company's Puerto Rico affiliate. At June 30, 2014, the Company estimated that the 2014 Performance Improvement Plan would result in pre-tax charges beginning in the fourth fiscal quarter of 2014 and through fiscal 2015 of $65 million to $72 million. As a result of the Companys continuing reexamination of how it commercially executes its business, during the three months ended December 31, 2014, the Company made changes to its distribution strategy in China. Primarily as a result of this decision, in December 2014 the Company increased the range of estimated pre-tax charges to be incurred under the 2014 Performance Improvement Plan through fiscal 2015 and now expects the amounts to be between $92 million and $99 million.
	The current estimated pre-tax charges for the 2014 Performance Improvement Plan consist of:
	(i) approximately $35 million to $41 million for changes to the Companys distribution strategy in China, and for exit and contract termination costs related to the closing of the Company's Puerto Rico affiliate, the exiting of unprofitable doors and changes in customer, distribution and supply chain relationships; (ii) approximately $12 million for employee severance and other related one-time costs (including those related to the closing of the Company's Puerto Rico affiliate); and
	(iii) approximately $45 million to $46 million related to asset impairments, including approximately $18 million to $19 million associated with intangible asset and inventory impairments and exit costs caused by the expiration, non-renewal or wind-down of fragrance license agreements, and $26 million associated with discontinuations of certain products, including $7.1 million related to certain Elizabeth Arden branded skincare and color products developed prior to the Elizabeth Arden brand repositioning.
	During the three and six months ended December 31 2014, we incurred approximately $22.6 million and $28.7 million, respectively, of pre-tax charges in connection with the 2014 Performance Improvement Plan. Since inception we have incurred approximately $84.6 million of pre-tax charges in connection with the 2014 Performance Improvement Plan. The pre-tax charges for the three and six months ended December 31, 2014 and since inception consisted of the following:
	Three Months Ended December 31, 2014:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns	$	12,582	$		$		$	12,582
	Inventory write-downs				4,542				4,542
	Asset impairments and related charges						77		77
	Severance and other employee-related costs						769		769
	Other						4,672		4,672
	Total	$	12,582	$	4,542	$	5,518	$	22,642
	Six Months Ended December 31, 2014:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns	$	15,261	$		$		$	15,261
	Inventory write-downs				4,580				4,580
	Asset impairments and related charges						138		138
	Severance and other employee-related costs						1,920		1,920
	Other						6,835		6,835
	Total	$	15,261	$	4,580	$	8,893	$	28,734
	Since Inception:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns (1)	$	24,725	$		$		$	24,725
	Inventory write-downs (2)				34,765				34,765
	Asset impairments and related charges(3)						9,812		9,812
	Severance and other employee-related costs(4)						7,958		7,958
	Other(5)						7,366		7,366
	Total	$	24,725	$	34,765	$	25,136	$	84,626
	(1) Related to changes in the Companys distribution strategy in China, the closing of the Companys Puerto Rico affiliate, exiting of unprofitable doors, changes in customer relationships and non-renewal and expiration of certain fragrance license agreements.
	(2) Related to the expiration, non-renewal and wind-down of fragrance license agreements and discontinuation of certain products.
	(3) Related primarily to the non-renewal and expiration of fragrance license agreements.
	(4) Severance and other employee-related costs associated with reduction in global headcount positions.
	(5) Consists primarily of transition expenses and customer and vendor contract termination costs.
	As of December 31, 2014, the related liability balance and activity for costs associated with the 2014 Performance Improvement Plan are as follows:
			Severance and
			Other Employee-
	(Amounts in thousands)		Related Costs			Other			Total
	Liability balance at June 30, 2014	$	5,427		$	531		$	5,958
	Accruals(1)		1,151			2,163			3,314
	Cash payments-First Quarter Fiscal 2015		(4,643	)		(2,694	)		(7,337	)
	Liability balance at September 30, 2014	$	1,935		$			$	1,935
	Accruals(1)		769			4,672			5,441
	Cash payments-Second Quarter Fiscal 2015		(1,102	)		(2,026	)		(3,128	)
	Liability balance at December 31, 2014 (2)	$	1,602		$	2,646		$	4,248
	(1) Included in selling, general and administrative expenses in the Company's consolidated statements of operations.
	(2) The Company expects to pay the balance of these liabilities during fiscal 2015.
	During the three and six months ended December 31, 2014, and in addition to the items discussed above under the 2014 Performance Improvement Plan, the Company recorded approximately $43.8 million in asset impairment charges primarily related to the write off of the Justin Bieber and Nicki Minaj licenses and other costs. See Note 7 for further discussion.
	All of the expenses discussed above, as described in Note 17, have not been attributed to any of the Companys reportable segments and are included in unallocated corporate expenses.

Noncontrolling_Interests

Noncontrolling Interests	6 Months Ended
	Dec. 31, 2014
Noncontrolling Interests [Abstract]
Noncontrolling Interests	NOTE 5. NONCONTROLLING INTERESTS
	On July 2, 2013, the Company, through a subsidiary (the "EA USC Subsidiary"), invested $6.0 million in US Cosmeceutechs, LLC ("USC"), a skin care company that develops and sells skin care products into the professional dermatology and spa channels. The investment, which is in the form of a collateralized convertible note (the Convertible Note) that bears interest at 1.5%, was convertible into 50% of the fully diluted equity interest of USC at any time at the option of the EA USC Subsidiary and also converted automatically upon the satisfaction of certain conditions.
	On July 11, 2013, the EA USC Subsidiary purchased a 30% equity interest in USC from the sole equity member (the "Member") for $3.6 million under the terms of a put-call agreement with the USC Member. Under the terms of the put-call agreement, the EA USC Subsidiary has an option to purchase the Member's remaining equity interest in USC at specified prices under certain circumstances based on USC's performance, and similarly the Member has the ability to put its interest in USC to the Company at specified prices under certain circumstances based on USC's performance. Based on the terms of the put-call agreement, it is likely that the EA USC Subsidiary would exercise its call option prior to the Member exercising his put option. In accordance with Topic 480, Distinguishing Liabilities from Equity, the Company is required to classify the noncontrolling interest in USC as a "redeemable noncontrolling interest" in the mezzanine section of the Company's consolidated balance sheet.
	In December 2014, the EA USC Subsidiary invested an additional $2.0 million in USC and an existing $1.0 million demand loan to USC was incorporated as part of the Convertible Note. As a result of these transactions, the Convertible Note was amended and restated to reflect (i) an aggregate principal amount of $9 million (including the previously outstanding demand loan), and (ii) that once converted, the Convertible Note will result in the Company owning 85.45% of the fully diluted equity interests in USC (inclusive of EA USCs current equity interest). The other terms of the Convertible Note remained unchanged. As a result of the December 2014 transactions, the Members remaining equity interest in USC that is subject to the put and call option is now 14.55%. As of December 31, 2014, the Convertible Note had not been converted.
	Under the terms of the operating agreement of USC, the EA USC Subsidiary has control of the board of managers of USC and the power to direct activities that could have a substantial impact on the economic performance of USC, including those that could result in the obligation to absorb losses or the right to receive benefits that could potentially be significant to USC. Based on the investment in USC and the EA USC Subsidiary's controlling rights under the operating agreement, the Company has determined that USC is a VIE, of which the Company is the primary beneficiary, requiring consolidation of USC's financial statements in accordance with Topic 810, Consolidation.
	The following provides an analysis of the change in the redeemable noncontrolling interest liability for the six months ended December 31, 2014:
	(Amounts in thousands)		Amount
	Beginning as of June 30, 2014	$	5,553
	Net loss attributable to noncontrolling interests		(915	)
	Balance at December 31, 2014	$	4,638

Inventories

Inventories	6 Months Ended
	Dec. 31, 2014
Inventories [Abstract]
Inventories	NOTE 6. INVENTORIES
	The components of inventory were as follows:
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	Raw materials	$	39,383	$	51,406
	Work in progress		12,419		22,262
	Finished goods		236,518		265,158
	Total	$	288,320	$	338,826

Exclusive_Brand_Licenses_Trade

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill	6 Months Ended
	Dec. 31, 2014
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill	NOTE 7. EXCLUSIVE BRAND LICENSES, TRADEMARKS AND INTANGIBLES, NET AND GOODWILL
	The following summarizes the cost basis amortization and weighted average estimated life associated with the Company's intangible assets:
								30-Jun-14
			December 31,			June 30,		Weighted Average
	(Amounts in thousands)		2014			2014		Estimated Life
	Elizabeth Arden brand trademarks	$	122,415		$	122,415		Indefinite
	Exclusive brand licenses and related trademarks		107,641			162,771		14
	Exclusive brand trademarks		105,262			102,064		16
	Other intangibles (1)		18,580			18,580		18
	Exclusive brand licenses, trademarks and intangibles, gross		353,898			405,830
	Accumulated amortization:
	Exclusive brand licenses and related trademarks		(63,094	)		(72,018	)
	Exclusive brand trademarks		(53,966	)		(52,185	)
	Other intangibles		(7,194	)		(6,623	)
	Exclusive brand licenses, trademarks and intangibles, net	$	229,644		$	275,004
	(1) Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.
	At December 31, 2014, the Company had goodwill of $31.6 million recorded on its consolidated balance sheet. The entire amount of the goodwill in all periods presented relates to the North America segment. The Company did not record any impairments during the three months ended December 31, 2014, as there were no events that triggered an impairment analysis.
	During the second quarter of fiscal 2015, net sales of Justin Bieber and Nicki Minaj fragrances fell significantly below expectations. The Company reviewed these license agreements for potential impairment. Given the significant decline in net sales during the second quarter of fiscal 2015 and the expectation for a continued decline of sales in future periods, the Company determined that these intangible assets were fully impaired. As a result, the Company recorded a total impairment charge of approximately $39.6 million during the second quarter of fiscal 2015 to write off the carrying values of both the Justin Bieber and Nicki Minaj licenses.
	Amortization expense was $4.6 million and $4.9 million for the three months ended December 31, 2014 and 2013, respectively, and $9.1 million and $9.8 million for the six months ended December 31, 2014 and 2013, respectively. At December 31, 2014, the Company estimated annual amortization expense for each of the next five fiscal years as shown in the following table. Future acquisitions, renewals or impairment events could cause these amounts to change.
			Remainder
	(Amounts in millions)		of 2015		2016		2017		2018		2019
	Amortization expense	$	6	$	11.5	$	10.2	$	9.8	$	9.4

Other_Payables_And_Accrued_Exp

Other Payables And Accrued Expenses	6 Months Ended
	Dec. 31, 2014
Other Payables And Accrued Expenses [Abstract]
Other Payables And Accrued Expenses	NOTE 8. OTHER PAYABLES AND ACCRUED EXPENSES
	A summary of the Company's other payables and accrued expenses is as follows:
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	Accrued advertising, promotion and royalties	$	44,686	$	29,613
	Accrued employee-related benefits		18,327		21,325
	Accrued value added taxes		7,740		5,077
	Accrued interest		7,862		7,939
	Freight		4,324		4,005
	Other accruals		39,860		43,994
	Total other payables and accrued expenses	$	122,799	$	111,953

ShortTerm_Debt

Short-Term Debt	6 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Short-Term Debt	NOTE 9. SHORT-TERM DEBT
	At December 31, 2014, the Company had a $275 million revolving bank credit facility ("the Credit Facility") with a syndicate of banks, for which JPMorgan Chase Bank is the administrative agent, which generally provides for borrowings on a revolving basis, with a sub-limit of $25 million for letters of credit. On January 7, 2015, the commitments under the Credit Facility were increased by an additional $25 million to a total of $300 million. In December 2014, the Credit Facility was amended to among other things, (i) extend its maturity date from January 2016 to December 2019, with a sublimit of $25 million for letters of credit, and (ii) revise the interest rate and unused commitment fee applicable under the Credit Facility. Under the terms of the Credit Facility, the Company may, at any time, increase the size of the Credit Facility up to $375 million without entering into a formal amendment requiring the consent of all of the banks, subject to the Company's satisfaction of certain conditions.
	The Credit Facility is guaranteed by all of the Company's U.S. subsidiaries and is collateralized by a first priority lien on all of the Company's U.S. accounts receivable and inventory. Borrowings under the Credit Facility are limited to 85% of eligible accounts receivable and 85% of the appraised net liquidation value of the Company's inventory, as determined pursuant to the terms of the Credit Facility; provided, however, that from August 15 to October 31 of each year the Company's borrowing base may be temporarily increased by up to $25 million.
	The Credit Facility, as amended, has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if (a) average borrowing base capacity (calculated on a rolling three-day basis) is equal to or less than ten percent (10%) of total borrowing availability under the Credit Facility, or (b) the Companys borrowing availability under the Credit Facility, plus domestic cash and cash equivalents, is less than $20 million at any time. The Company's average borrowing base capacity and borrowing availability during the quarter ended December 31, 2014, did not fall below the applicable thresholds noted above. Accordingly, the debt service coverage ratio did not apply for the quarter ended December 31, 2014.
	Under the terms of the Credit Facility, as amended, the Company may pay dividends or repurchase common stock if (a) it maintains a debt service coverage ratio of not less than 1.1 to 1.0 and maintains borrowing base capacity plus domestic cash and cash equivalents, in each case after giving effect to the applicable payment, of (i) at least $30 million from February 1 to August 31, and (ii) at least $35 million from September 1 to January 31, or (b) it maintains borrowing base capacity plus domestic cash and cash equivalents of (i) at least $40 million from February 1 to August 31, and (ii) at least $45 million from September 1 to January 31.
	Borrowings under the credit portion of the Credit Facility continue to bear interest at a floating rate based on an Applicable Margin that is determined by reference to a debt service pricing ratio. At the Companys option, the Applicable Margin may be applied to either the London InterBank Offered Rate (LIBOR) or the base rate. As amended, the Applicable Margin charged on LIBOR loans now ranges from 1.50% to 2.50%, as compared to 1.75% to 2.50% previously, and ranges from 0% to 1.0%, as compared to 0.25% to 1.0% previously, for base rate loans. The Applicable Margin on the first $25 million of borrowings from August 15 to October 31 of each year, while the temporary increase in the Companys borrowing base is in effect, is 1.0% higher. The unused commitment fee rate is now 0.375% per annum, as compared to 0.50% per annum previously, and is based on quarterly average utilization.
	At December 31, 2014, the Applicable Margin was 2.50% for LIBOR loans and 1.00% for base rate loans. The commitment fee on the unused portion of the Credit Facility at December 31, 2014 was 0.375%. For the six months ended December 31, 2014 and 2013, the weighted average annual interest rate on borrowings under the Credit Facility was 2.8% and 2.1%, respectively.
	The Company also has a second lien credit agreement (the "Second Lien Facility") with JPMorgan Chase Bank, N.A. providing the Company the ability to borrow up to $30 million on a revolving basis. The Second Lien Facility matures on January 2016. The Second Lien Facility is collateralized by a second priority lien on all of the Company's U.S. accounts receivable and inventories, and the interest on borrowings charged under the Second Lien Facility is either (i) LIBOR plus an applicable margin of 3.25% or (ii) the base rate specified in the Second Lien Facility (which is comparable to prime rates) plus a margin of 1.75%. The unused commitment fee applicable to the Second Lien Facility ranges from 0.25% to 0.375% based on the quarterly average unused portion of the Second Lien Facility. To the extent the Company borrows amounts under the Second Lien Facility, the Company has the option to prepay all or a portion of such borrowings, provided the borrowing base capacity under the Credit Facility is in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment.
	At December 31, 2014, the Company had $58.9 million in outstanding borrowings and approximately $3.1 million in letters of credit outstanding under the Credit Facility, compared with $78.0 million in borrowings and $3.3 million in letters of credit outstanding at June 30, 2014. At both December 31, 2014 and June 30, 2014, the Company had no outstanding borrowings under the Second Lien Facility. At December 31, 2014, based on eligible accounts receivable and inventory available as collateral, an additional $196.7 million in the aggregate could be borrowed under the Credit Facility and the Second Lien Facility. In periods when there are outstanding borrowings, the Company classifies the Credit Facility and Second Lien Facility as short term debt on its balance sheet because it expects to reduce outstanding borrowings over the next twelve months.
	In connection with the amendment of the Credit Facility in December 2014, the Company (i) recorded approximately $0.2 million of debt extinguishment costs in the second quarter of fiscal 2015, and (ii) incurred and capitalized approximately $2.0 million of bank related costs. Such amounts are reflected in debt financing costs, net, on the consolidated balance sheet.

LongTerm_Debt

Long-Term Debt	6 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Long-Term Debt	NOTE 10.
	LONG-TERM DEBT
	The Company's long-term debt consisted of the following:
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	7 3/8% Senior Notes due March 2021	$	350,000	$	350,000
	Unamortized premium on long-term debt		6,033		6,432
	Total long-term debt	$	356,033	$	356,432
	On January 21, 2011, the Company issued $250 million aggregate principal amount of 7 3/8% Senior Notes due March 2021 (the "7 3/8% Senior Notes"). Interest on the 7 3/8% Senior Notes accrues at a rate of 7.375% per annum and is payable semi-annually on March 15 and September 15 of every year. The 7 3/8% Senior Notes rank pari passu in right of payment to indebtedness under the Credit Facility and any other senior debt, and will rank senior to any future subordinated indebtedness provided, however, that the 7 3/8% Senior Notes are effectively subordinated to the Credit Facility and the Second Lien Facility to the extent of the collateral securing the Credit Facility and the Second Lien Facility. The indenture applicable to the 7 3/8% Senior Notes (the "Indenture") generally permits the Company (subject to the satisfaction of a fixed charge coverage ratio and, in certain cases, also a net income test) to incur additional indebtedness, pay dividends, purchase or redeem its Common Stock or redeem subordinated indebtedness. The Indenture generally limits the Company's ability to create liens, merge or transfer or sell assets. The Indenture also provides that the holders of the 7 3/8% Senior Notes have the option to require the Company to repurchase their notes in the event of a change of control involving the Company (as defined in the Indenture). The 7 3/8% Senior Notes are not currently guaranteed by any of the Company's subsidiaries but could become guaranteed in the future by any domestic subsidiary of the Company that guarantees or incurs certain indebtedness in excess of $10 million. In addition, as part of the offering of the 7 3/8% Senior Notes, the Company incurred and capitalized approximately $6.0 million of related debt financing costs on the consolidated balance sheet, which will be amortized over the life of the 7 3/8% Senior Notes.
	On January 30, 2014, the Company consummated the private placement pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), of an additional $100 million aggregate principal amount of 7 3/8% Senior Notes (the "Additional 7 3/8% Senior Notes") issued under a supplement to the Indenture. The original 7 3/8% Senior Notes issued on January 21, 2011 and the Additional 7 3/8% Senior Notes issued on January 30, 2014 are treated as a single series under the Indenture. The Additional 7 3/8% Senior Notes have the same terms as the original 7 3/8% Senior Notes. In connection with the offering of the Additional 7 3/8% Senior Notes, the Credit Facility and the Second Lien Facility were each amended to permit the issuance of additional 7 3/8% Senior Notes under the Indenture.
	The Additional 7 3/8% Senior Notes were sold at 106.75% of their principal amount, and the premium received will be amortized over the remaining life of the 7 3/8% Senior Notes. In addition, as part of the issuance of the Additional 7 3/8% Senior Notes, the Company incurred and capitalized approximately $2.2 million of related debt financing costs on the consolidated balance sheet, which will be amortized over the remaining life of the 7 3/8% Senior Notes. In March 2014, the Additional 7 3/8% Senior Notes were exchanged for an equivalent principal amount of notes registered under the Securities Act and containing identical terms to the Additional 7 3/8% Senior Notes.

Commitments_And_Contingencies

Commitments And Contingencies	6 Months Ended
	Dec. 31, 2014
Commitments And Contingencies [Abstract]
Commitments And Contingencies	NOTE 11. COMMITMENTS AND CONTINGENCIES
	During fiscal 2013 and 2014, the Company invested $9.7 million, including transaction costs, for a minority investment in Elizabeth Arden Salon Holdings, LLC, an unrelated party whose subsidiaries operate the Elizabeth Arden Red Door Spas and the Mario Tricoci Hair Salons ("Salon Holdings"). The investment, which is in the form of a collateralized convertible note bearing interest at 2%, has been accounted for using the cost method and at December 31, 2014, is included in other assets on the consolidated balance sheet. The Company entered into a co-investment agreement with another minority investor of Salon Holdings under which the minority investor has the ability to put its interest in Salon Holdings to the Company under certain circumstances, at a specified price based on the performance of Salon Holdings over the previous 12 month period.
	On February 2, 2015, the minority interest investor puts its interest in Salon Holdings to the Company. Based on the performance of Salon Holdings over the previous 12-month period, the Company expects to pay the minority investor approximately $4 million in cash during the third quarter of fiscal 2015.
	In July 2013, the Company acquired a 20% equity interest in a company that is developing a beauty device (the Device Company). Under the terms of the equity interest purchase agreement, the Company has an obligation to purchase an additional 20% equity interest at a cost of $6 million upon the achievement of certain milestones related to the development and shipment to customers of a beauty device. In conjunction with the purchase of the equity interest, the Company entered into a license with the Device Company to become the exclusive worldwide manufacturer, marketer and distributor of the beauty device. In addition, the Company also has an option to purchase the remaining 60% equity interest in the Device Company at a specified price under certain circumstances based on the sales performance of the device.
	The Company is a party to a number of legal actions, proceedings, audits, tax audits, claims and disputes, arising in the ordinary course of business, including those with current and former customers over amounts owed. While any action, proceeding, audit or claim contains an element of uncertainty and may materially affect the Company's cash flows and results of operations in a particular quarter or year, based on current facts and circumstances, the Company's management believes that the outcome of such actions, proceedings, audits, claims and disputes will not have a material adverse effect on the Company's business, prospects, results of operations, financial condition or cash flows.
	The Company and its domestic subsidiaries file income tax returns with federal, state and local tax authorities within the United States. The Company also files tax returns for its international affiliates in various foreign jurisdictions. The statute of limitations for the Company's U.S. federal tax returns remains open for the year ended June 30, 2010 and subsequent fiscal years. During the second quarter of fiscal 2014, the IRS began an examination of the Company's U.S. federal tax returns for the fiscal years ended June 30, 2010, 2011 and 2012. The year ended June 30, 2010, and subsequent fiscal years remain subject to examination for various state tax jurisdictions. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations generally ranging from one to five years. The year ended June 30, 2009, and subsequent fiscal years remain subject to examination for various foreign jurisdictions.

Redeemable_Preferred_Stock_And

Redeemable Preferred Stock And Warrants	6 Months Ended
	Dec. 31, 2014
Redeemable Preferred Stock And Warrants [Abstract]
Redeemable Preferred Stock And Warrants	NOTE 12. REDEEMABLE PREFERRED STOCK AND WARRANTS
	On August 19, 2014, the Company entered into a securities purchase agreement (the Securities Purchase Agreement) with Nightingale Onshore Holdings L.P. and Nightingale Offshore Holdings L.P. (each a Purchaser and together, the Purchasers), investment funds affiliated with Rhne Capital L.L.C. Pursuant to the Securities Purchase Agreement, for aggregate cash consideration of $50 million, the Company issued to the Purchasers an aggregate of 50,000 shares of the Companys newly designated Series A Serial Preferred Stock, par value $0.01 per share (the Preferred Stock), with detachable warrants to purchase up to 2,452,267 shares of the Companys Common Stock (the Warrants). Concurrently with the execution of the Securities Purchase Agreement, the Company also entered into a Shareholders Agreement with the Purchasers (the Shareholders Agreement). The issuance and sale of the Preferred Stock and Warrants were exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act), pursuant to Section 4(2) of the Securities Act and/or Regulation D promulgated under the Securities Act.
	Series A Serial Preferred Stock
	Dividends on the Preferred Stock are due on January 1, April 1, July 1 and October 1 of each year, commencing on October 1, 2014. The Preferred Stock will also participate in dividends declared or paid, whether in cash, securities or other property, on the shares of Common Stock for which the outstanding Warrants are exercisable. Dividends are payable at the per annum dividend rate of 5% of the liquidation preference, which is initially $1,000 per share (the Liquidation Preference). If and to the extent that the Company does not pay the entire dividend to which holders of the Preferred Stock are entitled for a particular period in cash on the applicable dividend payment date, preferential cash dividends will accrue on such unpaid amounts (and on any unpaid dividends in respect thereof) at 5% per annum, and will compound on each dividend payment date, until paid. No cash dividend may be declared or paid on Common Stock or other classes of stock over which the Preferred Stock has preference unless full cumulative dividends have been or contemporaneously are declared and paid in cash on the Preferred Stock. The Preferred Stock has an aggregate liquidation preference of $50 million, and ranks junior to all of the Companys liabilities and obligations to creditors with respect to assets available to satisfy claims against the Company and senior to all other classes of stock over which the Preferred Stock has preference, including the Common Stock. The Preferred Stock will not be convertible into Common Stock at any time.
	Pursuant to the Shareholders Agreement, each quarter the Company will declare and pay in cash no less than fifty percent (50%) of each dividend to which holders of Preferred Stock are entitled under the articles of amendment designating the rights of the Preferred Stock (the Articles of Amendment), unless payment of such dividend in cash (i) is prohibited by or would result in a default or event of default under the Companys indenture, credit facilities and certain other debt documents or (ii) would result in a breach of the legal or fiduciary obligations of the Board, in which case the Company will declare and pay in cash the maximum amount permitted to be paid in cash.
	The Preferred Stock is redeemable at the option of the holder at 100% of the Liquidation Preference plus an amount per share equal to accrued but unpaid dividends on the Preferred Stock up to the date of redemption, at any time after August 19, 2022. The Preferred Stock is also redeemable at the option of the Company at the following redemption prices and times:
	Percentage of Liquidation Preference of each		Timing of Redemption Right
	share of Preferred Stock to be redeemed *
	103	%	On or after August 19, 2016 but prior to August 19, 2019
	102	%	On or after August 19, 2019 but prior to August 19, 2020
	101	%	On or after August 19, 2020 but prior to August 19, 2021
	100	%	On or after August 19, 2021
	*In each case, plus an amount per share equal to accrued but unpaid dividends on such share of Preferred Stock up to, but excluding, the earlier of the date of the redemption or the date of constructive redemption.
	In the event of a Change of Control of the Company (as defined in the Company's Articles of Amendment) at a price per share of Common Stock below $24.00, the holders of the Preferred Stock will have the right to require the Company to repurchase each share of Preferred Stock held by such holder for cash at the following prices and times (provided that doing so does not cause a default or event of default under the Companys indenture, credit facilities and certain other debt documents and there are sufficient funds legally available therefor):
	Percentage of Liquidation Preference of each share		Change of Control Date
	of Preferred Stock to be repurchased *
	120	%	Prior to August 19, 2015
	110	%	On or after August 19, 2015 but prior to August 19, 2016
	105	%	On or after August 19, 2016 but prior to August 19, 2017
	101	%	On or after August 19, 2017
	*In each case, plus an amount per share equal to accrued but unpaid dividends on such share of Preferred Stock up to, but excluding, the earlier of the date of the redemption or the date of constructive redemption.
	So long as the Purchasers beneficially own a majority of the outstanding shares of Preferred Stock, the holders of a majority of such outstanding shares, voting separately as a class, will have the right (the Designation Rights) to elect the following number of directors to the board of directors of the Company at any meeting of shareholders of the Company (or by written consent) at which directors are to be elected, designated or appointed (the Board): (i) if the Percentage Interest (as defined in the Shareholders Agreement) as of the record date for such meeting (or action by written consent) is equal to or more than the percentage of Common Stock represented by the shares underlying the Warrants as of the date of issuance (approximately 7.6%) but less than 20%, one member of the Board; or (ii) if the Percentage Interest as of the record date for such meeting (or action by written consent) is equal to or greater than 20%, two members of the Board. As of October 24, 2014, the Purchasers Percentage Interest was approximately 20.2%. Effective on October 28, 2014, the Purchasers elected M. Steven Langman and Franz-Ferdinand Buerstedde to serve on the Board.
	Except as required by law or otherwise provided in the Articles of Amendment, the holders of shares of Preferred Stock will be entitled to vote together as one class with holders of the Company's Common Stock on all matters submitted to a vote of the Companys shareholders. Each share of Preferred Stock is entitled to a number of votes (rounded down to the nearest whole number) equal to (i) the aggregate number of shares of Common Stock for which the outstanding Warrants are exercisable (regardless of whether or not such Warrants could legally be exercised at such time and regardless of whether the holder of the Preferred Stock is also the holder of Warrants) divided by (ii) the number of outstanding shares of Preferred Stock, determined as of the record date for the determination of holders of Common Stock entitled to vote on any such matter.
	Warrants
	The exercise price for the Warrants is $20.39 per share (the Warrant Price), and they mature on August 19, 2024. The Warrant Price may be paid, at the option of the holder, in cash or by surrendering to the Company shares of Preferred Stock having an aggregate liquidation preference plus accrued and unpaid dividends equal to the aggregate exercise price. Alternatively, subject to certain exceptions in the case of a Mandatory Exercise (as defined below), if the market price (as determined pursuant to the Warrant) (the Market Price) of the Common Stock is greater than the Warrant Price, the holder may elect to surrender the Warrant and receive shares of Common Stock in respect of the Warrant equal to the value, as determined pursuant to the Warrant, of the Warrant, subject to certain restrictions.
	After August 19, 2019, the Company may require the exercise of the Warrants if the volume weighted average sale price for the Common Stock, as determined pursuant to the Warrant, exceeds 150% of the exercise price for ten (10) consecutive trading days (a Mandatory Exercise). Payment of the exercise price in the case of a Mandatory Exercise is required to be made first by surrender of shares of Preferred Stock held by the Warrant holder.
	The exercise price of the Warrants and the number of shares issuable upon exercise of the Warrants are subject to adjustment, as provided in the Warrants, including if the Company, on or after August 19, 2017, issues or sells Common Stock for a price lower than the Market Price of the Common Stock and the exercise price of the Warrants.
	Shareholders Agreement
	Under the terms of the Shareholders Agreement, from and after the date the Purchasers are no longer entitled, in their capacity as holders of Preferred Stock, to elect directors to the Board pursuant to their Designation Rights, the Purchasers will have the right to jointly designate for election one member to the Companys Board of Directors for so long as the Purchasers Percentage Interest (as defined in the Shareholders Agreement) is equal to or more than the percentage of Common Stock represented by the shares underlying the Warrants as of the date of issuance (approximately 7.6%) but less than 20%, and the right to designate for election an additional member to the Companys Board if the Purchasers have an aggregate Percentage Interest equal to or exceeding 20% of the Companys outstanding Common Stock.
	The Shareholders Agreement also imposes restrictions under certain circumstances on the Company's ability to, among other things, (i) amend the Companys articles of incorporation and bylaws, (ii) prior to August 19, 2017, issue or sell any Common Stock at a price per share less than the Warrant Price, and (iii) make certain restricted payments under the Indenture relating to the Companys Senior Notes. In addition, the Purchasers are entitled to preemptive rights under certain circumstances, as well as customary demand and piggyback registration rights relating to the shares of Common Stock underlying the Warrants.
	Financial Statement Presentation
	Upon issuance, the Preferred Stock has been classified as mezzanine equity on the consolidated balance sheet. Based on its terms, the Preferred Stock is considered contingently redeemable. The accounting guidance under Topic 480, Distinguishing Liabilities from Equity, requires preferred securities that are redeemable for cash or other assets to be classified outside of permanent equity if they are redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon the occurrence of an event that is not solely within the control of the issuer. The Warrants have been classified as equity on the balance sheet.
	Under Topic 480, if preferred shares are issued in conjunction with other securities, such as warrants, and the other securities meet the requirements for equity classification, the sales proceeds from the issuance should be allocated to each security based on their relative fair values. The fair value of the Preferred Stock was based on the present value of the dividends expected to be paid at the 5% annual rate over the next eight years until August 19, 2022, the first date that the preferred stock may be redeemed at the option of the holder at par, as well as the payment of the redemption amount of $50 million and any unpaid dividends due on August 19, 2022. In determining the fair value of the Warrants, given the possibility that the Warrants may be exercised at the Companys discretion under certain circumstances after August 19, 2019, as discussed above, the Company utilized a Monte Carlo simulation model using the assumptions below:
		Assumptions
	Expected dividend yield	0	%
	Expected price volatility	43.2	%
	Risk-free interest rate	2.4	%
	Expected term in years	10
	Based on the guidance under Topic 480, the initial value of the Preferred Stock and Warrants recorded on the consolidated balance sheet equaled the sales proceeds received from the issuance of the Preferred Stock, net of any direct issuance costs. The Company incurred approximately $6 million of costs directly associated with this transaction. The net proceeds of approximately $44 million were allocated to the Preferred Stock and Warrants as follows:
			Allocation of
	(Amounts in thousands)		Net Proceeds
	Preferred Stock	$	29,849
	Warrants		14,144
	Total	$	43,993
	Under current accounting guidance, because the Preferred Stock is not redeemable currently, but because it is probable it will become redeemable, the Preferred Stock should be adjusted to its maximum redemption amount at each balance sheet date. In addition, the Company had the option to choose to either (i) accrete changes in the redemption value of the Preferred Stock over the period from the date of issuance to the earliest redemption date of the security, or (ii) recognize changes in the redemption value of the Preferred Stock immediately and adjust the carrying value of the Preferred Stock to equal the redemption value at the end of each reporting period (this method would view the end of the reporting period as if it were also the redemption date for the Preferred Stock). The Company selected the second option and recognized the accretion immediately and recorded the full accretion in the first quarter of fiscal 2015. On September 29, 2014, the Board declared a dividend of approximately $295,000 on the Preferred Stock, and 50% of the dividend declared was paid on October 1, 2014. In addition, in October 2014, the Board declared a dividend of approximately $639,000, and 50% of the dividend declared was paid in January 2015. Accrued dividends payable as of December 31, 2014 were approximately $786,000 and dividend arrearage as of December 31, 2014 was approximately $147,000.
	The following table sets forth the accretion and dividends on the redeemable Preferred Stock for the three and six months ended December 31, 2014:
			Three Months		Six Months
			Ended		Ended
			December 31,		December 31,
	(Amounts in thousands)		2014		2014
	Preferred stock accretion to redemption value	$	--	$	20,151
	Dividends		639		934
	Total	$	639	$	21,085

Fair_Value_Measurements

Fair Value Measurements	6 Months Ended
	Dec. 31, 2014
Fair Value Measurements [Abstract]
Fair Value Measurements	NOTE 13. FAIR VALUE MEASUREMENTS
	Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The accounting standards also have established a fair value hierarchy, which prioritizes the inputs to valuation techniques used in measuring fair value into three broad levels as follows:
	Level 1 - Quoted prices in active markets for identical assets or liabilities
	Level 2 - Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly Level 3 - Unobservable inputs based on the Company's own assumptions
	The Company's long-term debt consists of $350 million aggregate principal amount of its 7 3/8% Senior Notes. At December 31, 2014 and June 30, 2014, the estimated fair value of the 7 3/8% Senior Notes was as follows:
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	7 3/8% Senior Notes due March 2021 (Level 2)	$	321,125	$	369,250
	The Company determined the estimated fair value amounts by using available market information and commonly accepted valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value, primarily due to the illiquid nature of the capital markets in which the 7 3/8% Senior Notes are traded. The use of different assumptions and/or estimation methodologies may have a material effect on the estimated fair value.
	The Company's derivative assets and liabilities are currently composed of foreign currency contracts. Fair values are based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions.
	The following table presents the fair value hierarchy for the Company's financial assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2014 and June 30, 2014:
	(Amounts in thousands)	31-Dec-14				30-Jun-14
			Asset		Liability		Asset		Liability
	Level 2		1,924		518		--		2,522
	Total	$	1,924	$	518	$	--	$	2,522
	See Note 14 for a discussion of the Company's foreign currency contracts.
	Accounting standards require non-financial assets and liabilities to be recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. During the second quarter of fiscal 2015, the Company recorded an asset impairment charge of approximately $39.6 million to write off the carrying values of both the Justin Bieber and Nicki Minaj licenses. See Note 7. As of December 31, 2014, other than the carrying values of these licenses, the Company did not have any non-financial assets and liabilities measured at fair value.

Derivative_Financial_Instrumen

Derivative Financial Instruments	6 Months Ended
	Dec. 31, 2014
Derivative Financial Instruments [Abstract]
Derivative Financial Instruments	NOTE 14. DERIVATIVE FINANCIAL INSTRUMENTS
	The Company operates in several foreign countries, which exposes it to market risk associated with foreign currency exchange rate fluctuations. The Company's risk management policy is to enter into cash flow hedges to reduce a portion of the exposure of the Company's foreign subsidiaries' revenues to fluctuations in currency rates using foreign currency forward contracts. The Company also enters into cash flow hedges for a portion of its forecasted inventory purchases to reduce the exposure of its Canadian and Australian subsidiaries' cost of sales to such fluctuations, as well as cash flow hedges for a portion of its subsidiaries' forecasted Swiss franc operating costs. The principal currencies hedged are British pounds, Euros, Canadian dollars, Australian dollars and Swiss francs. The Company does not enter into derivative financial contracts for speculative or trading purposes. The Company's derivative financial instruments are recorded in the consolidated balance sheets at fair value determined using pricing models based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions. Cash flows from derivative financial instruments are classified as cash flows from operating activities in the consolidated statements of cash flows. Foreign currency contracts used to hedge forecasted revenues are designated as cash flow hedges. These contracts are used to hedge forecasted revenues generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive (loss) income within shareholders' equity to the extent such contracts are effective, and are recognized in net sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three and six months ended December 31, 2014 or in fiscal 2014 relating to foreign currency contracts used to hedge forecasted revenues resulting from hedge ineffectiveness. As of December 31, 2014, the Company had notional amounts of 6.4 million British pounds and 8.7 million Euros under foreign currency contracts that expire between January 31, 2015 and May 31, 2015 to reduce the exposure of our foreign subsidiary revenues to fluctuations in currency rates.
	Foreign currency contracts used to hedge forecasted cost of sales or operating costs are designated as cash flow hedges. These contracts are used to hedge the forecasted cost of sales of the Company's Canadian and Australian subsidiaries or operating costs of the Company's Swiss subsidiaries generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive (loss) income within shareholders' equity, to the extent such contracts are effective, and are recognized in cost of sales or selling, general and administrative expenses in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three and six months ended December 31, 2014 or in fiscal 2014 relating to foreign currency contracts used to hedge forecasted cost of sales or forecasted operating costs resulting from hedge ineffectiveness. As of December 31, 2014, the Company had notional amounts under foreign currency contracts of (i) 4.7 million Canadian dollars and 4.3 million Australian dollars used to hedge forecasted cost of sales that expire between January 31, 2015 and May 31, 2015, and (ii) 18.3 million Swiss francs used to hedge forecasted operating costs that expire between January 31, 2015 and May 31, 2016.
	When appropriate, the Company also enters into and settles foreign currency contracts for Euros, British pounds, Canadian dollars and Australian dollars to reduce exposure of the Company's foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. These contracts are used to hedge balance sheet exposure generally over one month and are settled before the end of the month in which they are entered into. Changes to fair value of the forward contracts are recognized in selling, general and administrative expense in the period in which the contracts expire. For the three and six months ended December 31, 2014, the Company recorded gains of $1.0 million and $2.2 million, respectively in selling, general and administrative expenses related to these contracts. Amounts recorded for the three months ended December 31, 2013, were not material. For the six months ended December 31, 2013, the Company recorded losses of $0.7 in selling, general and administrative expenses related to these contracts. As of December 31, 2014, there were no such foreign currency contracts outstanding. There were no amounts recorded in the three and six months ended December 31, 2014 or in fiscal 2014 relating to foreign currency contracts to hedge subsidiary balance sheets resulting from hedge ineffectiveness.
	The following tables illustrate the fair value of outstanding foreign currency contracts and the gains (losses) associated with the settlement of these contracts:
			Fair Value of Derivative
			Instruments Designated as
	(Amounts in thousands)		Effective Hedges
			December 31,		June 30,
	Balance Sheet Location		2014		2014
	Other assets	$	1,924	$	--
	Other payables	$	518	$	2,522
	Gain (Loss) Reclassified from Accumulated Other Comprehensive (Loss) Income into (Loss) Income, Net of Tax (Effective Portion)
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,			December 31,			December 31,			December 31,
			2014			2013			2014			2013
	Currency Contracts - Net Sales (1)	$	545		$	(418	)	$	397		$	(362	)
	Currency Contracts - Cost of Sales (2)		90			(39	)		21			(32	)
	Currency Contracts - Selling, General
	and Administrative Expenses (3)		(8	)		145			(8	)		182
	Total (4)	$	627		$	(312	)	$	410		$	(212	)
	(1) Recorded in net sales on the consolidated statements of operations.
	(2) Recorded in cost of sales on the consolidated statements of operations.
	(3) Recorded in selling, general and administrative expenses on the consolidated statements of operations.
	(4) Net of tax expense of $103 for the three months ended December 31, 2014, and net of tax benefit of $56 for the three months ended December 31, 2013. Net of tax expense of $83 for the six months ended December 31, 2014, and net of tax benefit of $43 for the six months ended December 31, 2013.
	Net (Loss) Gain Recognized in Other Comprehensive (Loss) Income on Derivatives, Net of Tax (Effective Portion)
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,			December 31,			December 31,			December 31,
			2014			2013			2014			2013
	Currency Contracts - Net Sales	$	(172	)	$	(424	)	$	2,722		$	(2,109	)
	Currency Contracts - Cost of Sales		(41	)		390			635			289
	Currency Contracts - Selling, general
	and administrative expenses		(437	)		(194	)		(462	)		125
	Total (1)	$	(650	)	$	(228	)	$	2,895		$	(1,695	)
	(1) Net of tax expense of $42 and $181 for the three months ended December 31, 2014 and 2013, respectively. Net of tax expense of $540 for the six months ended December 31, 2014, and net of tax benefit of $21 for the six months ended December 31, 2013.

Repurchases_Of_Common_Stock

Repurchases Of Common Stock	6 Months Ended
	Dec. 31, 2014
Repurchases Of Common Stock [Abstract]
Repurchases Of Common Stock	NOTE 15. REPURCHASES OF COMMON STOCK
	The Company has an existing stock repurchase program pursuant to which the Company's Board has authorized the repurchase of $120 million of Common Stock and that was scheduled to expire on November 30, 2014. On August 5, 2014, the Companys Board extended the stock repurchase program through November 30, 2016.
	For the six months ended December 31, 2014, there were no share repurchases under the Common Stock repurchase program. As of December 31, 2014, the Company had repurchased 4,517,309 shares of Common Stock on the open market under the stock repurchase program since its inception in November 2005, at an average price of $18.88 per share and at a cost of approximately $85.3 million, including sales commissions, leaving approximately $34.7 million available for additional repurchases under the program. The acquisition of these shares was accounted for under the treasury method.

New_Accounting_Standards_And_T

New Accounting Standards And Tax Legislation	6 Months Ended
	Dec. 31, 2014
New Accounting Standards And Tax Legislation [Abstract]
New Accounting Standards And Tax Legislation	NOTE 16. NEW ACCOUNTING STANDARDS AND TAX LEGISLATION
	In May 2014, the FASB and the International Accounting Standards Board jointly issued a converged standard, Topic 606, Revenue From Contracts With Customers. The new standard will require companies to recognize revenue to depict the transfer of goods or services to customers in amounts that reflect the consideration to which the company expects to be entitled in exchange for those goods or services. The new standard also will result in enhanced disclosures about revenue, provide guidance for transactions that were not previously addressed comprehensively and improve guidance for multiple-element arrangements. The new standard is effective for the Company beginning July 1, 2017, including interim periods within that reporting period. The new standard is required to be applied retrospectively. Early application is not permitted. The Company is currently evaluating the impact of the new standard on its consolidated financial statements.
	In June 2014, the FASB issued an update to Topic 718, Compensation-Stock Compensation. This update requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. This update is intended to resolve the diverse accounting treatment of those awards in practice, and requires that the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The new standard is effective for the Company beginning July 1, 2016. The new guidance can be applied either prospectively or retrospectively and early application is permitted. As of December 31, 2014, the Company had no outstanding awards to which this new guidance would apply.
	On December 19, 2014, the Tax Increase Prevention Act of 2014 (H.R. 5771) was signed into law extending certain expiring provisions, including the Section 41 research credit. The new legislation applies retrospectively to January 1, 2014 through December 31, 2014 and resulted in an estimated net tax benefit of approximately $100,000 for fiscal year 2014, which was recorded on a discrete basis in the second quarter of fiscal 2015. This tax benefit was fully offset by a U.S. valuation allowance.

Segment_Data_And_Related_Infor

Segment Data And Related Information	6 Months Ended
	Dec. 31, 2014
Segment Data And Related Information [Abstract]
Segment Data And Related Information	NOTE 17. SEGMENT DATA AND RELATED INFORMATION
	Reportable operating segments, as defined by Codification Topic 280, Segment Reporting, include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the "Chief Executive") in deciding how to allocate resources and in assessing performance. As a result of the similarities in the procurement, marketing and distribution processes for all of the Company's products, much of the information provided in the consolidated financial statements is similar to, or the same as, that reviewed on a regular basis by the Chief Executive.
	At December 31, 2014, the Company's operations were organized into the following two operating segments, which also comprise its reportable segments:
	North America - The North America segment sells the Company's portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to prestige retailers, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes the Company's direct to consumer business, which is composed of the Elizabeth Arden branded retail outlet stores and the Company's e-commerce business. This segment also sells Elizabeth Arden products through the Red Door Spa beauty salons and spas, which are owned and operated by a third party licensee in which the Company has a minority investment.
	International - The International segment sells a portfolio of owned and licensed brands, including Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.
	The Chief Executive evaluates segment profit based upon income from operations, which represents earnings before income taxes, interest expense and depreciation and amortization charges. The accounting policies for each of the reportable segments are the same as those described in the Company's 2014 Annual Report under Note 1 -- "General Information and Summary of Significant Accounting Policies."
	The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information regarding assets and liabilities of the Company's reportable segments is produced for the Chief Executive or included herein.
	Segment net sales and profit (loss) exclude returns and markdowns related to the 2014 Performance Improvement Plan. In addition, segment profit (loss) excludes depreciation and amortization, interest expense, debt extinguishment charges, and consolidation and elimination adjustments and unallocated corporate costs and expenses, which are shown in the table reconciling segment profit (loss) to consolidated income (loss) before income taxes. Included in unallocated corporate costs and expenses are (i) restructuring charges that are related to an announced plan, (ii) restructuring costs for corporate operations, and (iii) costs and expenses related to the 2014 Performance Improvement Plan, including sales returns and markdowns. These expenses are recorded in unallocated corporate expenses as these items are centrally directed and controlled and are not included in internal measures of segment operating performance. The Company does not have any intersegment sales.
	The following table is a comparative summary of the Company's net sales and segment profit (loss) by operating segment for the three and six months ended December 31, 2014 and 2013:
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,		December 31,				December 31,		December 31,
			2014			2013			2014		2013
	Segment Net Sales:
	North America	$	227,275		$	269,647		$	399,634		$	494,306
	International		118,914			148,490			219,612			267,440
	Total	$	346,189		$	418,137		$	619,246		$	761,746
	Reconciliation:
	Segment Net Sales	$	346,189		$	418,137		$	619,246		$	761,746
	Less:
	Unallocated sales returns and markdowns		(12,582	)(1)		--			(15,261	)(1)		--
	Net Sales	$	333,607		$	418,137		$	603,985		$	761,746
	Segment Profit:
	North America	$	30,565		$	33,960		$	43,386		$	62,847
	International		1,917			14,822			(9,546	)		6,880
	Total	$	32,482		$	48,782		$	33,840		$	69,727
	Reconciliation:
	Segment Profit	$	32,482		$	48,782		$	33,840		$	69,727
	Less:
	Depreciation and Amortization		12,755			13,124			25,467			25,653
	Interest Expense, net		7,712			5,734			15,468			11,766
	Consolidation and Elimination
	Adjustments		1,436			630			1,515			(1,363	)
	Unallocated Corporate Expenses		66,645	-2		(15,746	)(3)		72,737	-4		(13,371	)(5)
	(Loss) Income Before Income Taxes	$	(56,066	)	$	45,040		$	(81,347	)	$	47,042
	(1) Amounts for the three and six months ended December 31, 2014, represent $12.6 million and $15.3 million, respectively, of returns and markdowns under the Companys 2014 Performance Improvement Plan primarily due to changes to the Companys distribution strategy in China and other customer and distribution arrangements.
	(2) In addition to the returns and markdowns described above in Note 1, amounts for the three months ended December 31, 2014, include:
	$10.0 million in costs and expenses under the 2014 Performance Improvement Plan comprised of $4.6 million of inventory write-downs due to discontinuation of certain products, $4.5 million comprised primarily of customer and vendor contract termination costs, and $0.9 million of severance, other employee-related expenses and related transition costs associated with the reduction in global headcount positions;
	$43.8 million in asset impairment charges primarily related to the write off of the Justin Bieber and Nicki Minaj licenses and other costs; and
	$0.2 million of debt extinguishment costs resulting from the December 2014 amendment to the Credit Facility.
	(3) Amounts for the three months ended December 31, 2013, include:
	a credit of $17.2 million for the complete reversal of the remaining balance of the contingent liability for potential payments to Give Back Brands, LLC based on the Companys determination during the second quarter of fiscal 2014 that it was not probable that the performance targets related to the Justin Bieber and Nicki Minaj licenses for fiscal years 2014 and 2015 would be met; and
	$1.4 million of severance and other employee-related expenses and related transition costs incurred with respect to the elimination of certain sales positions and other staff positions announced in the fall of 2013.
	(4) In addition to the returns and markdowns described above in Note 1, amounts for the six months ended December 31, 2014, include:
	$13.4 million in costs and expenses under the 2014 Performance Improvement Plan comprised of $4.6 million of inventory write-downs due to discontinuation of certain products, $4.5 million primarily comprised of customer and vendor contract termination costs, $4.2 million of severance, other employee-related expenses and related transition costs associated with the reduction in global headcount positions, and $0.1 million in asset impairment charges;
	$43.8 million in asset impairment charges primarily related to the write off of the Justin Bieber and Nicki Minaj licenses and other costs; and
	$0.2 million of debt extinguishment costs resulting from the December 2014 amendment to the Credit Facility.
	(5) Amounts for the six months ended December 31, 2013, include:
	a credit of $17.2 million for the complete reversal of the remaining balance of the contingent liability for potential payments to Give Back Brands, LLC based on the Companys determination during the second quarter of fiscal 2014 that it was not probable that the performance targets related to the Justin Bieber and Nicki Minaj licenses for fiscal years 2014 and 2015 would be met; and
	$3.8 million of severance and other employee-related expenses and related transition costs incurred with respect to the elimination of certain sales positions and other staff positions announced in the fall of 2013.

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Loss [Abstract]
Schedule Of Accumulated Other Comprehensive Loss			December 31,			June 30,
	(Amounts in thousands)		2014			2014
	Cumulative foreign currency translation adjustments	$	(12,139	)	$	(2,622	)
	Unrealized hedging gains (losses), net of taxes (1)		1,142			(2,163	)
	Accumulated other comprehensive loss	$	(10,997	)	$	(4,785	)
	(1) Net of tax expense of $265 as of December 31, 2014 and net of tax benefit of $359 as of June 30, 2014.

Net_Loss_Income_Per_Share_Attr1

Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders (Tables)	6 Months Ended
	Dec. 31, 2014
Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders [Abstract]
Schedule Of Earnings Per Share, Basic And Diluted
	(Amounts in thousands, except per
	share data)		Three Months Ended					Six Months Ended
			December 31,			December 31,		December 31,			December 31,
			2014			2013		2014			2013
	Basic
	Net (loss) income attributable to Elizabeth
	Arden common shareholders	$	(56,778	)	$	34,953	$	(102,574	)	$	36,650
	Weighted average shares outstanding		29,812			29,649		29,796			29,648
	Net (loss) income per basic share
	attributable
	to Elizabeth Arden common
	shareholders	$	(1.90	)	$	1.18	$	(3.44	)	$	1.24
	Diluted
	Net (loss) income attributable to Elizabeth
	Arden common shareholders	$	(56,778	)	$	34,953	$	(102,574	)	$	36,650
	Weighted average shares outstanding		29,812			29,649		29,796			29,648
	Potential common shares - treasury
	method		--			480		--			534
	Weighted average shares and potential
	dilutive common shares		29,812			30,129		29,796			30,182
	Net (loss) income per diluted share
	attributable to Elizabeth Arden common
	shareholders	$	(1.90	)	$	1.16	$	(3.44	)	$	1.21
Schedule Of Common Stock Options, Restricted Stock, And Restricted Stock Unit Awards Outstanding Not Included In Net (Loss) Income Per Diluted Share
	(Amounts in thousands)	Three Months Ended		Six Months Ended
		December 31,	December 31,	December 31,	December 31,
		2014	2013	2014	2013
	Number of shares	3,276	104	3,276	81

2014_Performance_Improvement_P1

2014 Performance Improvement Plan And Other Restructuring (Tables)	6 Months Ended
	Dec. 31, 2014
2014 Performance Improvement Plan And Other Restructuring [Abstract]
Schedule Of Pre-Tax Charges In Connection With 2014 Performance Improvement Plan	Three Months Ended December 31, 2014:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns	$	12,582	$		$		$	12,582
	Inventory write-downs				4,542				4,542
	Asset impairments and related charges						77		77
	Severance and other employee-related costs						769		769
	Other						4,672		4,672
	Total	$	12,582	$	4,542	$	5,518	$	22,642
	Six Months Ended December 31, 2014:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns	$	15,261	$		$		$	15,261
	Inventory write-downs				4,580				4,580
	Asset impairments and related charges						138		138
	Severance and other employee-related costs						1,920		1,920
	Other						6,835		6,835
	Total	$	15,261	$	4,580	$	8,893	$	28,734
	Since Inception:
					Cost of		Selling,
					Goods		General and
	(Amounts in thousands)		Net Sales		Sold		Administrative		Total
	Returns and markdowns (1)	$	24,725	$		$		$	24,725
	Inventory write-downs (2)				34,765				34,765
	Asset impairments and related charges(3)						9,812		9,812
	Severance and other employee-related costs(4)						7,958		7,958
	Other(5)						7,366		7,366
	Total	$	24,725	$	34,765	$	25,136	$	84,626
	(1) Related to changes in the Companys distribution strategy in China, the closing of the Companys Puerto Rico affiliate, exiting of unprofitable doors, changes in customer relationships and non-renewal and expiration of certain fragrance license agreements.
	(2) Related to the expiration, non-renewal and wind-down of fragrance license agreements and discontinuation of certain products.
	(3) Related primarily to the non-renewal and expiration of fragrance license agreements.
	(4) Severance and other employee-related costs associated with reduction in global headcount positions.
	(5) Consists primarily of transition expenses and customer and vendor contract termination costs.
Schedule Of Related Liability Balance And Activity For Costs Associated With 2014 Performance Improvement Plan			Severance and
			Other Employee-
	(Amounts in thousands)		Related Costs			Other			Total
	Liability balance at June 30, 2014	$	5,427		$	531		$	5,958
	Accruals(1)		1,151			2,163			3,314
	Cash payments-First Quarter Fiscal 2015		(4,643	)		(2,694	)		(7,337	)
	Liability balance at September 30, 2014	$	1,935		$			$	1,935
	Accruals(1)		769			4,672			5,441
	Cash payments-Second Quarter Fiscal 2015		(1,102	)		(2,026	)		(3,128	)
	Liability balance at December 31, 2014 (2)	$	1,602		$	2,646		$	4,248
	(1) Included in selling, general and administrative expenses in the Company's consolidated statements of operations.
	(2) The Company expects to pay the balance of these liabilities during fiscal 2015.

Noncontrolling_Interests_Table

Noncontrolling Interests (Tables)	6 Months Ended
	Dec. 31, 2014
Noncontrolling Interests [Abstract]
Schedule Of Change In Redeemable Noncontrolling Interest Liability
	(Amounts in thousands)		Amount
	Beginning as of June 30, 2014	$	5,553
	Net loss attributable to noncontrolling interests		(915	)
	Balance at December 31, 2014	$	4,638

Inventories_Tables

Inventories (Tables)	6 Months Ended
	Dec. 31, 2014
Inventories [Abstract]
Summary Of Inventory
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	Raw materials	$	39,383	$	51,406
	Work in progress		12,419		22,262
	Finished goods		236,518		265,158
	Total	$	288,320	$	338,826

Exclusive_Brand_Licenses_Trade1

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Tables)	6 Months Ended
	Dec. 31, 2014
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]
Summary Of Intangible Assets
								30-Jun-14
			December 31,			June 30,		Weighted Average
	(Amounts in thousands)		2014			2014		Estimated Life
	Elizabeth Arden brand trademarks	$	122,415		$	122,415		Indefinite
	Exclusive brand licenses and related trademarks		107,641			162,771		14
	Exclusive brand trademarks		105,262			102,064		16
	Other intangibles (1)		18,580			18,580		18
	Exclusive brand licenses, trademarks and intangibles, gross		353,898			405,830
	Accumulated amortization:
	Exclusive brand licenses and related trademarks		(63,094	)		(72,018	)
	Exclusive brand trademarks		(53,966	)		(52,185	)
	Other intangibles		(7,194	)		(6,623	)
	Exclusive brand licenses, trademarks and intangibles, net	$	229,644		$	275,004
	(1) Primarily consists of customer relationships, customer lists, non-compete agreements and product formulas.
Schedule Of Expected Amortization Expense
			Remainder
	(Amounts in millions)		of 2015		2016		2017		2018		2019
	Amortization expense	$	6	$	11.5	$	10.2	$	9.8	$	9.4

Other_Payables_And_Accrued_Exp1

Other Payables And Accrued Expenses (Tables)	6 Months Ended
	Dec. 31, 2014
Other Payables And Accrued Expenses [Abstract]
Summary Of Other Payables And Accrued Expenses
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	Accrued advertising, promotion and royalties	$	44,686	$	29,613
	Accrued employee-related benefits		18,327		21,325
	Accrued value added taxes		7,740		5,077
	Accrued interest		7,862		7,939
	Freight		4,324		4,005
	Other accruals		39,860		43,994
	Total other payables and accrued expenses	$	122,799	$	111,953

LongTerm_Debt_Tables

Long-Term Debt (Tables)	6 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Summary Of Long-Term Debt
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	7 3/8% Senior Notes due March 2021	$	350,000	$	350,000
	Unamortized premium on long-term debt		6,033		6,432
	Total long-term debt	$	356,033	$	356,432

Redeemable_Preferred_Stock_And1

Redeemable Preferred Stock And Warrants (Tables)	6 Months Ended
	Dec. 31, 2014
Redeemable Preferred Stock And Warrants [Abstract]
Schedule Of Preferred Stock Liquidation Preference
	Percentage of Liquidation Preference of each		Timing of Redemption Right
	share of Preferred Stock to be redeemed *
	103	%	On or after August 19, 2016 but prior to August 19, 2019
	102	%	On or after August 19, 2019 but prior to August 19, 2020
	101	%	On or after August 19, 2020 but prior to August 19, 2021
	100	%	On or after August 19, 2021
	*In each case, plus an amount per share equal to accrued but unpaid dividends on such share of Preferred Stock up to, but excluding, the earlier of the date of the redemption or the date of constructive redemption.
Schedule Of Preferred Stock Liquidation Preference In The Event Of Change Of Control	Percentage of Liquidation Preference of each share		Change of Control Date
	of Preferred Stock to be repurchased *
	120	%	Prior to August 19, 2015
	110	%	On or after August 19, 2015 but prior to August 19, 2016
	105	%	On or after August 19, 2016 but prior to August 19, 2017
	101	%	On or after August 19, 2017
	*In each case, plus an amount per share equal to accrued but unpaid dividends on such share of Preferred Stock up to, but excluding, the earlier of the date of the redemption or the date of constructive redemption.
Schedule Of Assumptions Used To Determine The Fair Value Of Warrants
		Assumptions
	Expected dividend yield	0	%
	Expected price volatility	43.2	%
	Risk-free interest rate	2.4	%
	Expected term in years	10
Schedule Of Net Proceeds Allocated To Preferred Stock And Warrants
			Allocation of
	(Amounts in thousands)		Net Proceeds
	Preferred Stock	$	29,849
	Warrants		14,144
	Total	$	43,993
Schedule Of Accretion And Dividends On Redeemable Preferred Stock
			Three Months		Six Months
			Ended		Ended
			December 31,		December 31,
	(Amounts in thousands)		2014		2014
	Preferred stock accretion to redemption value	$	--	$	20,151
	Dividends		639		934
	Total	$	639	$	21,085

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	6 Months Ended
	Dec. 31, 2014
Fair Value Measurements [Abstract]
Schedule Of Estimated Fair Values Of Long Term Debt
			December 31,		June 30,
	(Amounts in thousands)		2014		2014
	7 3/8% Senior Notes due March 2021 (Level 2)	$	321,125	$	369,250
Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis
	(Amounts in thousands)	31-Dec-14				30-Jun-14
			Asset		Liability		Asset		Liability
	Level 2		1,924		518		--		2,522
	Total	$	1,924	$	518	$	--	$	2,522

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	6 Months Ended
	Dec. 31, 2014
Derivative Financial Instruments [Abstract]
Schedule Of Foreign Exchange Contracts And The Gains (Losses) Associated With The Settlement Of Contracts
			Fair Value of Derivative
			Instruments Designated as
	(Amounts in thousands)		Effective Hedges
			December 31,		June 30,
	Balance Sheet Location		2014		2014
	Other assets	$	1,924	$	--
	Other payables	$	518	$	2,522
Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income Into (Loss) Income, Net Of Tax (Effective Portion)
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,			December 31,			December 31,			December 31,
			2014			2013			2014			2013
	Currency Contracts - Net Sales (1)	$	545		$	(418	)	$	397		$	(362	)
	Currency Contracts - Cost of Sales (2)		90			(39	)		21			(32	)
	Currency Contracts - Selling, General
	and Administrative Expenses (3)		(8	)		145			(8	)		182
	Total (4)	$	627		$	(312	)	$	410		$	(212	)
	(1) Recorded in net sales on the consolidated statements of operations.
	(2) Recorded in cost of sales on the consolidated statements of operations.
	(3) Recorded in selling, general and administrative expenses on the consolidated statements of operations.
	(4) Net of tax expense of $103 for the three months ended December 31, 2014, and net of tax benefit of $56 for the three months ended December 31, 2013. Net of tax expense of $83 for the six months ended December 31, 2014, and net of tax benefit of $43 for the six months ended December 31, 2013.
Net (Loss) Gain Recognized In Other Comprehensive (Loss) Income On Derivatives, Net Of Tax (Effective Portion)
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,			December 31,			December 31,			December 31,
			2014			2013			2014			2013
	Currency Contracts - Net Sales	$	(172	)	$	(424	)	$	2,722		$	(2,109	)
	Currency Contracts - Cost of Sales		(41	)		390			635			289
	Currency Contracts - Selling, general
	and administrative expenses		(437	)		(194	)		(462	)		125
	Total (1)	$	(650	)	$	(228	)	$	2,895		$	(1,695	)
	(1) Net of tax expense of $42 and $181 for the three months ended December 31, 2014 and 2013, respectively. Net of tax expense of $540 for the six months ended December 31, 2014, and net of tax benefit of $21 for the six months ended December 31, 2013.

Segment_Data_And_Related_Infor1

Segment Data And Related Information (Tables)	6 Months Ended
	Dec. 31, 2014
Segment Data And Related Information [Abstract]
Comparative Summary Of Net Sales And Segment Profit (Loss) By Operating Segment
	(Amounts in thousands)		Three Months Ended						Six Months Ended
			December 31,		December 31,				December 31,		December 31,
			2014			2013			2014		2013
	Segment Net Sales:
	North America	$	227,275		$	269,647		$	399,634		$	494,306
	International		118,914			148,490			219,612			267,440
	Total	$	346,189		$	418,137		$	619,246		$	761,746
	Reconciliation:
	Segment Net Sales	$	346,189		$	418,137		$	619,246		$	761,746
	Less:
	Unallocated sales returns and markdowns		(12,582	)(1)		--			(15,261	)(1)		--
	Net Sales	$	333,607		$	418,137		$	603,985		$	761,746
	Segment Profit:
	North America	$	30,565		$	33,960		$	43,386		$	62,847
	International		1,917			14,822			(9,546	)		6,880
	Total	$	32,482		$	48,782		$	33,840		$	69,727
	Reconciliation:
	Segment Profit	$	32,482		$	48,782		$	33,840		$	69,727
	Less:
	Depreciation and Amortization		12,755			13,124			25,467			25,653
	Interest Expense, net		7,712			5,734			15,468			11,766
	Consolidation and Elimination
	Adjustments		1,436			630			1,515			(1,363	)
	Unallocated Corporate Expenses		66,645	-2		(15,746	)(3)		72,737	-4		(13,371	)(5)
	(Loss) Income Before Income Taxes	$	(56,066	)	$	45,040		$	(81,347	)	$	47,042
	(1) Amounts for the three and six months ended December 31, 2014, represent $12.6 million and $15.3 million, respectively, of returns and markdowns under the Companys 2014 Performance Improvement Plan primarily due to changes to the Companys distribution strategy in China and other customer and distribution arrangements.
	(2) In addition to the returns and markdowns described above in Note 1, amounts for the three months ended December 31, 2014, include:
	$10.0 million in costs and expenses under the 2014 Performance Improvement Plan comprised of $4.6 million of inventory write-downs due to discontinuation of certain products, $4.5 million comprised primarily of customer and vendor contract termination costs, and $0.9 million of severance, other employee-related expenses and related transition costs associated with the reduction in global headcount positions;
	$43.8 million in asset impairment charges primarily related to the write off of the Justin Bieber and Nicki Minaj licenses and other costs; and
	$0.2 million of debt extinguishment costs resulting from the December 2014 amendment to the Credit Facility.
	(3) Amounts for the three months ended December 31, 2013, include:
	a credit of $17.2 million for the complete reversal of the remaining balance of the contingent liability for potential payments to Give Back Brands, LLC based on the Companys determination during the second quarter of fiscal 2014 that it was not probable that the performance targets related to the Justin Bieber and Nicki Minaj licenses for fiscal years 2014 and 2015 would be met; and
	$1.4 million of severance and other employee-related expenses and related transition costs incurred with respect to the elimination of certain sales positions and other staff positions announced in the fall of 2013.
	(4) In addition to the returns and markdowns described above in Note 1, amounts for the six months ended December 31, 2014, include:
	$13.4 million in costs and expenses under the 2014 Performance Improvement Plan comprised of $4.6 million of inventory write-downs due to discontinuation of certain products, $4.5 million primarily comprised of customer and vendor contract termination costs, $4.2 million of severance, other employee-related expenses and related transition costs associated with the reduction in global headcount positions, and $0.1 million in asset impairment charges;
	$43.8 million in asset impairment charges primarily related to the write off of the Justin Bieber and Nicki Minaj licenses and other costs; and
	$0.2 million of debt extinguishment costs resulting from the December 2014 amendment to the Credit Facility.
	(5) Amounts for the six months ended December 31, 2013, include:
	a credit of $17.2 million for the complete reversal of the remaining balance of the contingent liability for potential payments to Give Back Brands, LLC based on the Companys determination during the second quarter of fiscal 2014 that it was not probable that the performance targets related to the Justin Bieber and Nicki Minaj licenses for fiscal years 2014 and 2015 would be met; and
	$3.8 million of severance and other employee-related expenses and related transition costs incurred with respect to the elimination of certain sales positions and other staff positions announced in the fall of 2013.

Business_And_Basis_Of_Presenta1

Business And Basis Of Presentation (Details) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014
Business And Basis Of Presentation [Line Items]
Valuation allowance recorded against Canadian deferred tax assets	$2.50
Income tax expense recorded on a discrete basis	$2.10
International [Member]
Business And Basis Of Presentation [Line Items]
Number of countries company operates in	120

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss (Details) (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Accumulated Other Comprehensive Loss [Abstract]
Cumulative foreign currency translation adjustments	($12,139)	($2,622)
Unrealized hedging gains (losses), net of taxes	1,142	-2,163
Accumulated other comprehensive loss	-10,997	-4,785
Net unrealized hedging gains, tax expense (benefit)	$265	($359)

Net_Loss_Income_Per_Share_Attr2

Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders (Schedule of Earnings Per Share, Basic And Diluted) (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2014
Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders [Abstract]
Common stock, par value	$0.01		$0.01		$0.01
Net (loss) income attributable to Elizabeth Arden common shareholders	($56,778)	$34,953	($102,574)	$36,650
Weighted average shares outstanding	29,812	29,649	29,796	29,648
Net (loss) income per basic share attributable to Elizabeth Arden common shareholders	($1.90)	$1.18	($3.44)	$1.24
Potential common shares - treasury method		480		534
Weighted average shares and potential dilutive common shares	29,812	30,129	29,796	30,182
Net (loss) income per diluted share attributable to Elizabeth Arden common shareholders	($1.90)	$1.16	($3.44)	$1.21

Net_Loss_Income_Per_Share_Attr3

Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders (Schedule Of Common Stock Options, Restricted Stock, And Restricted Stock Unit Awards Outstanding Not Included In Net (Loss) Income Per Diluted Share) (Details)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Net (Loss) Income Per Share Attributable To Elizabeth Arden Common Shareholders [Abstract]
Number of shares	3,276	104	3,276	81

2014_Performance_Improvement_P2

2014 Performance Improvement Plan And Other Restructuring (Narrative) (Details) (USD $)	6 Months Ended	3 Months Ended	6 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2014	Jun. 30, 2014
Discontinuations Of Certain Products [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	$26,000,000
Brand Repositioning [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	7,100,000
2014 Performance Improvement Plan [Member]
Restructuring Cost and Reserve [Line Items]
Number of positions eliminated	175
Restructuring Charges	28,700,000	22,600,000	84,600,000
Asset impairments and related charges	138,000	77,000	9,812,000
2014 Performance Improvement Plan [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs		92,000,000		65,000,000
2014 Performance Improvement Plan [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs		99,000,000		72,000,000
2014 Performance Improvement Plan [Member] | Changes To Greater China E-Commerce Business And Exit And Contract Termination Costs Related To Closing Puerto Rico Affiliate [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	35,000,000
2014 Performance Improvement Plan [Member] | Changes To Greater China E-Commerce Business And Exit And Contract Termination Costs Related To Closing Puerto Rico Affiliate [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	41,000,000
2014 Performance Improvement Plan [Member] | Severance And Other Employee Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	12,000,000
2014 Performance Improvement Plan [Member] | Asset Impairments [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	45,000,000
2014 Performance Improvement Plan [Member] | Asset Impairments [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	46,000,000
2014 Performance Improvement Plan [Member] | Intangible Asset And Inventory Impairments [Member] | Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	18,000,000
2014 Performance Improvement Plan [Member] | Intangible Asset And Inventory Impairments [Member] | Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Expected restructuring expenses and related transition costs	19,000,000
Justin Beiber and Nicki Minaj Brand [Member] | 2014 Performance Improvement Plan [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairments and related charges	$43,800,000	$43,800,000

2014_Performance_Improvement_P3

2014 Performance Improvement Plan And Other Restructuring (Schedule Of Pre-Tax Charges In Connection With 2014 Performance Improvement Plan) (Details) (2014 Performance Improvement Plan [Member], USD $)	3 Months Ended	6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2014
Restructuring Cost and Reserve [Line Items]
Returns and markdowns	$12,582	$15,261	$24,725
Inventory write-downs	4,542	4,580	34,765
Asset impairments and related charges	77	138	9,812
Severance and other employee-related costs	769	1,920	7,958
Other	4,672	6,835	7,366
Total	22,642	28,734	84,626
Net Sales [Member]
Restructuring Cost and Reserve [Line Items]
Returns and markdowns	12,582	15,261	24,725
Total	12,582	15,261	24,725
Cost Of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Inventory write-downs	4,542	4,580	34,765
Total	4,542	4,580	34,765
Selling, General And Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Asset impairments and related charges	77	138	9,812
Severance and other employee-related costs	769	1,920	7,958
Other	4,672	6,835	7,366
Total	$5,518	$8,893	$25,136

2014_Performance_Improvement_P4

2014 Performance Improvement Plan And Other Restructuring (Schedule Of Related Liability Balance And Activity For Costs Associated With 2014 Performance Improvement Plan) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014
Restructuring Cost and Reserve [Line Items]
Liability balance	$1,935	$5,958
Accruals	5,441	3,314
Cash payments	-3,128	-7,337
Liability balance	4,248	1,935
Severance And Other Employee Related Costs [Member]
Restructuring Cost and Reserve [Line Items]
Liability balance	1,935	5,427
Accruals	769	1,151
Cash payments	-1,102	-4,643
Liability balance	1,602	1,935
Other Restructuring [Member]
Restructuring Cost and Reserve [Line Items]
Liability balance		531
Accruals	4,672	2,163
Cash payments	-2,026	-2,694
Liability balance	$2,646

Noncontrolling_Interests_Narra

Noncontrolling Interests (Narrative) (Details) (USD $)	6 Months Ended	1 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Jul. 02, 2013	Jul. 12, 2013	Jul. 11, 2013
Schedule of Equity Method Investments [Line Items]
Impairment charge	$42,931,000
US Cosmeceutechs, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Amount of investment			6,000,000
Collateralized convertible note, interest rate			1.50%
Percentage of fully diluted equity interest, investment can convert to			50.00%
Device Company [Member]
Schedule of Equity Method Investments [Line Items]
Percentage of equity interest purchased				20.00%
EA USC Subsidiary [Member] | US Cosmeceutechs, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Amount of investment					3,600,000
Percentage of equity interest purchased					30.00%
Additional investment	2,000,000	2,000,000
Demand loan included as part of Convertible Note	1,000,000	1,000,000
Convertible Note, aggregate principal amount	$9,000,000	$9,000,000
Percentage of fully diluted equity interests owned once Convertible Note is converted		85.45%
Percentage of Members remaining equity interest subject to put and call option		14.55%

Noncontrolling_Interests_Sched

Noncontrolling Interests (Schedule Of Change In Redeemable Noncontrolling Interest Liability) (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]
Beginning as of June 30, 2014			$5,553
Net loss attributable to noncontrolling interests	-760	-297	-915	-406
Balance at December 31, 2014	4,638		4,638
US Cosmeceutechs, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Beginning as of June 30, 2014			5,553
Net loss attributable to noncontrolling interests			-915
Balance at December 31, 2014	$4,638		$4,638

Inventories_Details

Inventories (Details) (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Inventories [Abstract]
Raw materials	$39,383	$51,406
Work in progress	12,419	22,262
Finished goods	236,518	265,158
Total	$288,320	$338,826

Exclusive_Brand_Licenses_Trade2

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2014
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]
Goodwill	$31,607,000		$31,607,000		$31,607,000
Adjustments for impairment of Justin Bieber and Nicki Minaj licenses	39,600,000
Amortization expense	$4,600,000	$4,900,000	$9,100,000	$9,800,000

Exclusive_Brand_Licenses_Trade3

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Summary Of Intangible Assets) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2014
Finite Lived And Indefinite Lived Intangible Assets [Line Items]
Elizabeth Arden brand trademarks	$122,415	$122,415
Exclusive brand licenses, trademarks and intangibles, gross	405,830	353,898
Exclusive brand licenses, trademarks and intangibles, net	275,004	229,644
Exclusive Brand Licenses And Related Trademarks [Member]
Finite Lived And Indefinite Lived Intangible Assets [Line Items]
Elizabeth Arden brand trademarks	162,771	107,641
Weighted Average Estimated Life	14 years
Accumulated amortization	-72,018	-63,094
Exclusive Brand Trademarks [Member]
Finite Lived And Indefinite Lived Intangible Assets [Line Items]
Elizabeth Arden brand trademarks	102,064	105,262
Weighted Average Estimated Life	16 years
Accumulated amortization	-52,185	-53,966
Other Intangibles [Member]
Finite Lived And Indefinite Lived Intangible Assets [Line Items]
Elizabeth Arden brand trademarks	18,580	18,580
Weighted Average Estimated Life	18 years
Accumulated amortization	($6,623)	($7,194)

Exclusive_Brand_Licenses_Trade4

Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill (Schedule Of Expected Amortization Expense) (Details) (USD $)	Dec. 31, 2014
In Millions, unless otherwise specified
Exclusive Brand Licenses, Trademarks And Intangibles, Net And Goodwill [Abstract]
Amortization expense, Remainder of 2015	$6
Amortization expense, 2016	11.5
Amortization expense, 2017	10.2
Amortization expense, 2018	9.8
Amortization expense, 2019	$9.40

Other_Payables_And_Accrued_Exp2

Other Payables And Accrued Expenses (Details) (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Other Payables And Accrued Expenses [Abstract]
Accrued advertising, promotion and royalties	$44,686	$29,613
Accrued employee-related benefits	18,327	21,325
Accrued value added taxes	7,740	5,077
Accrued interest	7,862	7,939
Freight	4,324	4,005
Other accruals	39,860	43,994
Total other payables and accrued expenses	$122,799	$111,953

ShortTerm_Debt_Details

Short-Term Debt (Details) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2014	Jul. 02, 2012	Dec. 31, 2013	Jun. 30, 2014	Jan. 07, 2015	Feb. 11, 2013
Line of Credit Facility [Line Items]
Applicable margin of borrowing from August 15 to October 31 of each year			$25,000,000
Temporary increase in borrowing base in effect			1.00%
Commitment fee percentage			0.38%
Weighted average interest rate	2.80%	2.80%	2.80%		2.10%
Debt Extinguishment charges		239,000	239,000
Bank related costs incurred and capitalized	2,000,000
Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage			0.50%
Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage			0.38%
JPMorgan Chase Bank [Member]
Line of Credit Facility [Line Items]
Revolving bank credit facility, current	275,000,000	275,000,000	275,000,000
Credit facility, maximum	375,000,000	375,000,000	375,000,000
Maximum borrowing capacity based on percentage of accounts receivable percentage			85.00%
Maximum borrowing capacity based on percentage of inventory percentage			85.00%
Amount by which borrowing base may be temporarily increased from August 15 to October 31 of each year			25,000,000
Number of financial maintenance covenants			1
Line of credit, amount outstanding	58,900,000	58,900,000	58,900,000			78,000,000
Letters of credit outstanding	3,100,000	3,100,000	3,100,000			3,300,000
Remaining borrowing capacity	196,700,000	196,700,000	196,700,000
JPMorgan Chase Bank [Member] | Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Credit facility expiration date	1-Jan-16
JPMorgan Chase Bank [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Credit facility expiration date	1-Dec-19
Line of credit facility debt service coverage ratio			1.1
Average borrowing base capacity of total availability under credit facility, minimum covenant trigger threshold			10.00%
Average borrowing base capacity minimum covenant trigger threshold			20,000,000
Line of credit facility debt service coverage ratio for payment of dividends or to repurchase common stock			1.1
Average borrowing base capacity minimum covenant trigger threshold for Company to pay dividends or to repurchase Common Stock from February 1 to August 31			30,000,000
Average borrowing base capacity minimum covenant trigger threshold for Company to pay dividends or to repurchase Common Stock from September 1 to January 31			35,000,000
Average borrowing base capacity plus domestic cash and cash equivalents minimum covenant trigger threshold for Company to pay dividends or to repurchase Common Stock from February 1 to August 31			40,000,000
Average borrowing base capacity plus domestic cash and cash equivalents minimum covenant trigger threshold for Company to pay dividends or to repurchase Common Stock from September 1 to January 31			45,000,000
JPMorgan Chase Bank [Member] | Subsequent Event [Member]
Line of Credit Facility [Line Items]
Revolving bank credit facility, current							300,000,000
Credit facility, increase in borrowing capacity							25,000,000
Base Rate Loans [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.00%
LIBOR Loans [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			2.50%
Second Lien Term Loan [Member] | JPMorgan Chase Bank [Member]
Line of Credit Facility [Line Items]
Credit facility, maximum	30,000,000	30,000,000	30,000,000
Line of credit, amount outstanding	0	0	0			0
Remaining borrowing capacity								35,000,000
Term loan maturity date			1-Jan-16
Length of measurement period for prepayment				30 days
Second Lien Term Loan [Member] | JPMorgan Chase Bank [Member] | London Interbank Offered Rate (LIBOR) [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate				3.25%
Second Lien Term Loan [Member] | JPMorgan Chase Bank [Member] | Base Rate [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate				1.75%
Letters of Credit [Member] | JPMorgan Chase Bank [Member]
Line of Credit Facility [Line Items]
Revolving bank credit facility, current	25,000,000	25,000,000	25,000,000
Letters of Credit [Member] | JPMorgan Chase Bank [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Revolving bank credit facility, current	$25,000,000	$25,000,000	$25,000,000
Maximum [Member] | Base Rate Loans [Member] | Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.00%
Maximum [Member] | Base Rate Loans [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.00%
Maximum [Member] | LIBOR Loans [Member] | Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			2.50%
Maximum [Member] | LIBOR Loans [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			2.50%
Maximum [Member] | Second Lien Term Loan [Member] | JPMorgan Chase Bank [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage				0.38%
Minimum [Member] | Base Rate Loans [Member] | Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			0.25%
Minimum [Member] | Base Rate Loans [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			0.00%
Minimum [Member] | LIBOR Loans [Member] | Old Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.75%
Minimum [Member] | LIBOR Loans [Member] | Amended Credit Facility [Member]
Line of Credit Facility [Line Items]
Basis spread on variable rate			1.50%
Minimum [Member] | Second Lien Term Loan [Member] | JPMorgan Chase Bank [Member]
Line of Credit Facility [Line Items]
Commitment fee percentage				0.25%

LongTerm_Debt_Narrative_Detail

Long-Term Debt (Narrative) (Details) (USD $)	0 Months Ended	6 Months Ended
	Jan. 30, 2014	Dec. 31, 2014	Jun. 30, 2014	Jan. 21, 2011
Debt Instrument [Line Items]
Aggregate principle amount		$350,000,000
Debt financing costs, net		8,103,000	7,225,000
7 3/8% Senior Notes [Member]
Debt Instrument [Line Items]
Aggregate principle amount				250,000,000
Debt instrument, stated interest rate	7.38%	7.38%	7.38%	7.38%
Debt instrument, maturity		1-Mar-21
Indebtedness or guarantees over which domestic subsidiary guarantees the company's debt		10,000,000
Debt financing costs, net		6,000,000
Additional aggregate principal amount issued	100,000,000
Percentage of principal amount Senior Notes were sold at		106.75%
Debt financing costs, incurred and capitalized		$2,200,000

LongTerm_Debt_Summary_Of_LongT

Long-Term Debt (Summary Of Long-Term Debt) (Details) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Jun. 30, 2014	Jan. 30, 2014	Jan. 21, 2011
Debt Instrument [Line Items]
Unamortized premium on long-term debt	$6,033	$6,432
Total long-term debt	356,033	356,432
7 3/8% Senior Notes [Member]
Debt Instrument [Line Items]
Total long-term debt	$350,000	$350,000
Debt instrument, stated interest rate	7.38%	7.38%	7.38%	7.38%
Debt instrument, maturity	1-Mar-21

Commitments_And_Contingencies_

Commitments And Contingencies (Details) (USD $)	3 Months Ended	6 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Jun. 30, 2014	Jun. 30, 2013	Jul. 12, 2013
Debt Instrument [Line Items]
Reversal of contingent liability	$17.20		$17.20
Investment in companies					9.7	9.7
Term that Elizabeth Arden Salon Holdings is measured for to determine price		12 months
Scenario, Forecast [Member]
Debt Instrument [Line Items]
Expected cash payment to minority investor				4
2% Secured Convertible Debt [Member]
Debt Instrument [Line Items]
Debt instrument, stated interest rate		2.00%
Minimum [Member]
Debt Instrument [Line Items]
Statute of limitations for subsidiaries in foreign jurisdictions		1 year
Maximum [Member]
Debt Instrument [Line Items]
Statute of limitations for subsidiaries in foreign jurisdictions		5 years
Device Company [Member]
Debt Instrument [Line Items]
Percentage of equity interest purchased							20.00%
Additional equity interest obligated to purchase		20.00%
Cost of additional equity interest obligated to purchase		$6
Remaining equity interest available to purchase		60.00%

Redeemable_Preferred_Stock_And2

Redeemable Preferred Stock And Warrants (Narrative) (Details) (USD $)	0 Months Ended	6 Months Ended	0 Months Ended		1 Months Ended	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2014	Sep. 29, 2014	Aug. 19, 2014	Oct. 31, 2014	Dec. 31, 2014	Oct. 24, 2014	Oct. 01, 2014	Jan. 31, 2015
Class of Stock [Line Items]
Preferred stock, shares issued	50,000	50,000				50,000
Preferred stock, par value	$0.01	$0.01				$0.01
Purchasers Percentage Interest							20.20%
Dividends declared		$934,000
Accrued dividends payable	786,000	786,000				786,000
Dividend arrearage	147,000
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Proceeds from issuance of preferred stock				50,000,000
Preferred stock, shares issued				50,000
Preferred stock, par value				$0.01
Preferred Stock, dividend rate		5.00%
Preferred Stock, liquidation preference per share	$1,000	$1,000				$1,000
Preferred Stock, liquidation preference value	50,000,000	50,000,000				50,000,000
Liquidation preference after August 19, 2022		100.00%		100.00%
Warrants issued as a percentage of common stock outstanding		7.60%
Number of members of the Board elected if Percentage Interest is less than 20%		1
Number of members of the Board elected if Percentage Interest is equal to or greater than 20%		2
Exercise price of warrants	$20.39	$20.39				$20.39
Warrants redeemable exercise price percentage		150.00%
Warrants redeemable exercise price consecutive trading days		10 days
Period the dividends are expected to be paid over		8 years
Preferred Stock, redemption amount	50,000,000	50,000,000				50,000,000
Preferred Stock, issuance costs incurred		6,000,000
Net proceeds allocated to Preferred Stock and Warrants		43,993,000
Dividends declared		$934,000	$295,000		$639,000	$639,000
Percentage of dividend declared that was paid								50.00%
Series A Serial Preferred Stock [Member] | Minimum [Member]
Class of Stock [Line Items]
Percentage of each dividend of preferred stock paid in cash		50.00%
Fair market value per share	$24	$24				$24
Percentage Interest for election of two members of the Board		20.00%
Series A Serial Preferred Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Number of shares called by warrants				2,452,267
Percentage Interest for election of one member of the Board		20.00%
Subsequent Event [Member] | Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Percentage of dividend declared that was paid									50.00%

Redeemable_Preferred_Stock_And3

Redeemable Preferred Stock And Warrants (Schedule Of Preferred Stock Liquidation Preference) (Details) (Series A Serial Preferred Stock [Member])	0 Months Ended	6 Months Ended
	Aug. 19, 2014	Dec. 31, 2014
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Liquidation preference in year two through four	103.00%
Liquidation preference in year four and five	102.00%
Liquidation preference in year five and six	101.00%
Liquidation preference thereafter	100.00%	100.00%

Redeemable_Preferred_Stock_And4

Redeemable Preferred Stock And Warrants (Schedule Of Preferred Stock Liquidation Preference In The Event Of Change Of Control) (Details) (Series A Serial Preferred Stock [Member])	0 Months Ended
	Aug. 19, 2014
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Liquidation preference, change of control, year one	120.00%
Liquidation preference, change of control, year two	110.00%
Liquidation preference, change of control, year three	105.00%
Liquidation preference, change of control, thereafter	101.00%

Redeemable_Preferred_Stock_And5

Redeemable Preferred Stock And Warrants (Schedule Of Assumptions Used To Determine The Fair Value Of Warrants) (Details) (Series A Serial Preferred Stock [Member])	6 Months Ended
	Dec. 31, 2014
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Expected dividend yield	0.00%
Expected price volatility	43.20%
Risk-free interest rate	2.40%
Expected term in years	10 years

Redeemable_Preferred_Stock_And6

Redeemable Preferred Stock And Warrants (Schedule Of Net Proceeds Allocated To Preferred Stock And Warrants) (Details) (Series A Serial Preferred Stock [Member], USD $)	6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock	$29,849
Warrants	14,144
Total	$43,993

Redeemable_Preferred_Stock_And7

Redeemable Preferred Stock And Warrants (Schedule Of Accretion And Dividends On Redeemable Preferred Stock) (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended	6 Months Ended
	Sep. 29, 2014	Oct. 31, 2014	Dec. 31, 2014	Dec. 31, 2014
Class of Stock [Line Items]
Preferred stock accretion to redemption value				$20,151,000
Dividends				934,000
Total			639,000	21,085,000
Series A Serial Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock accretion to redemption value				20,151,000
Dividends	295,000	639,000	639,000	934,000
Total			$639,000	$21,085,000

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	3 Months Ended
	Dec. 31, 2014	Jun. 30, 2014	Jan. 30, 2014	Jan. 21, 2011
Debt Instrument [Line Items]
Aggregate principle amount	$350,000,000
Adjustments for impairment of Justin Bieber and Nicki Minaj licenses	39,600,000
7 3/8% Senior Notes [Member]
Debt Instrument [Line Items]
Aggregate principle amount				$250,000,000
Debt instrument, stated interest rate	7.38%	7.38%	7.38%	7.38%

Fair_Value_Measurements_Schedu

Fair Value Measurements (Schedule Of Estimated Fair Values Of Long Term Debt) (Details) (7 3/8% Senior Notes [Member], USD $)	6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Jun. 30, 2014	Jan. 30, 2014	Jan. 21, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, stated interest rate	7.38%	7.38%	7.38%	7.38%
Debt instrument, maturity	1-Mar-21
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
7 3/8% Senior Notes due	321,125	369,250

Fair_Value_Measurements_Schedu1

Fair Value Measurements (Schedule Of Fair Value, Assets And Liabilities Measured On Recurring Basis) (Details) (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset	$1,924
Liability	518	2,522
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Asset	1,924
Liability	$518	$2,522

Derivative_Financial_Instrumen2

Derivative Financial Instruments (Narrative) (Details) (Currency Contracts [Member])

3 Months Ended

6 Months Ended

12 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

3 Months Ended

6 Months Ended

Dec. 31, 2014

Dec. 31, 2014

Jun. 30, 2014

Dec. 31, 2014

Dec. 31, 2014

Jun. 30, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Jun. 30, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2014

Dec. 31, 2013

USD ($)

USD ($)

USD ($)

Net Sales [Member]

Net Sales [Member]

Net Sales [Member]

Net Sales [Member]

Net Sales [Member]

Net Sales [Member]

Net Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Cost Of Sales [Member]

Selling, General And Administrative Expenses [Member]

Selling, General And Administrative Expenses [Member]

Selling, General And Administrative Expenses [Member]

USD ($)

USD ($)

USD ($)

EUR (€)

GBP (£)

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

AUD

CAD

CHF

Minimum [Member]

Maximum [Member]

USD ($)

USD ($)

USD ($)

Derivative [Line Items]

Term foreign currency cash flow hedges are hedged

12 months

24 months

12 months

24 months

Amount recorded resulting from hedge ineffectiveness relating to foreign currency contracts

$0

$0

$0

$0

$0

$0

$0

$0

$0

Derivative, notional amount

8,700,000

6,400,000

4,300,000

4,700,000

18,300,000

Recorded gains (losses) related to forward contracts

$1,000,000

$2,200,000

($700,000)

Derivative_Financial_Instrumen3

Derivative Financial Instruments (Schedule Of Foreign Exchange Contracts And The Gains (Losses) Associated With The Settlement Of Contracts) (Details) (USD $)	Dec. 31, 2014	Jun. 30, 2014
In Thousands, unless otherwise specified
Derivative Financial Instruments [Abstract]
Other assets	$1,924
Other payables	$518	$2,522

Derivative_Financial_Instrumen4

Derivative Financial Instruments (Gain (Loss) Reclassified From Accumulated Other Comprehensive (Loss) Income Into (Loss) Income, Net Of Tax (Effective Portion)) (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)	$627	($312)	$410	($212)
Tax (benefit) expense	103	-56	83	-43
Net Sales [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)	545	-418	397	-362
Cost Of Sales [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)	90	-39	21	-32
Selling, General And Administrative Expenses [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)	($8)	$145	($8)	$182

Derivative_Financial_Instrumen5

Derivative Financial Instruments (Net (Loss) Gain Recognized In Other Comprehensive (Loss) Income On Derivatives, Net Of Tax (Effective Portion)) (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Derivative Instruments, Gain (Loss) [Line Items]
Net (Loss) Gain Recognized in Other Comprehensive Income (Loss) on Derivatives, Net of Tax (Effective Portion)	($650)	($228)	$2,895	($1,695)
Tax expense (benefit)	42	181	540	-21
Net Sales [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net (Loss) Gain Recognized in Other Comprehensive Income (Loss) on Derivatives, Net of Tax (Effective Portion)	-172	-424	2,722	-2,109
Cost Of Sales [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net (Loss) Gain Recognized in Other Comprehensive Income (Loss) on Derivatives, Net of Tax (Effective Portion)	-41	390	635	289
Selling, General And Administrative Expenses [Member] | Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Net (Loss) Gain Recognized in Other Comprehensive Income (Loss) on Derivatives, Net of Tax (Effective Portion)	($437)	($194)	($462)	$125

Repurchases_Of_Common_Stock_De

Repurchases Of Common Stock (Details) (USD $)	6 Months Ended	110 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2014
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount	$120
Stock repurchase program, expiration date	30-Nov-16
Common stock repurchased, shares		4,517,309
Average price of common stock repurchased		$18.88
Cost of common stock repurchased		85.3
Stock repurchase program, remaining amount	$34.70
Previous Maturity Date Of Stock Repurchase Program [Member]
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, expiration date	30-Nov-14

New_Accounting_Standards_And_T1

New Accounting Standards And Tax Legislation (Details) (USD $)	3 Months Ended
	Dec. 31, 2014
New Accounting Standards And Tax Legislation [Abstract]
Estimated net tax benefit	$100,000

Segment_Data_And_Related_Infor2

Segment Data And Related Information (Narrative) (Details)	6 Months Ended
	Dec. 31, 2014
	segment
Segment Reporting Information [Line Items]
Number of operating segments	2
International [Member]
Segment Reporting Information [Line Items]
Number of countries company operates in	120

Segment_Data_And_Related_Infor3

Segment Data And Related Information (Comparative Summary Of Net Sales And Segment Profit (Loss) By Operating Segment) (Details) (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Segment Reporting Information [Line Items]
Net Sales	$333,607,000	$418,137,000	$603,985,000	$761,746,000
Depreciation and Amortization	12,755,000	13,124,000	25,467,000	25,653,000
Interest expense, net	7,712,000	5,734,000	15,468,000	11,766,000
Consolidation and Elimination Adjustments	1,436,000	630,000	1,515,000	-1,363,000
Unallocated Corporate Expenses	66,645,000	-15,746,000	72,737,000	-13,371,000
(Loss) income before income taxes	-56,066,000	45,040,000	-81,347,000	47,042,000
Complete reversal of remaining balance of contingent liability for potential payments to Give Back Brands LLC		17,200,000		17,200,000
Debt Extinguishment charges	239,000		239,000
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net Sales	346,189,000	418,137,000	619,246,000	761,746,000
Profit	32,482,000	48,782,000	33,840,000	69,727,000
Operating Segments [Member] | North America [Member]
Segment Reporting Information [Line Items]
Net Sales	227,275,000	269,647,000	399,634,000	494,306,000
Profit	30,565,000	33,960,000	43,386,000	62,847,000
Operating Segments [Member] | International [Member]
Segment Reporting Information [Line Items]
Net Sales	118,914,000	148,490,000	219,612,000	267,440,000
Profit	1,917,000	14,822,000	-9,546,000	6,880,000
Unallocated Sales Returns And Markdowns [Member]
Segment Reporting Information [Line Items]
Net Sales	-12,582,000		-15,261,000
2014 Performance Improvement Plan [Member]
Segment Reporting Information [Line Items]
Expenses and transition costs related to restructuring	10,000,000		13,400,000
Inventory write-downs	4,542,000		4,580,000		34,765,000
Asset impairments and related charges	77,000		138,000		9,812,000
2014 Performance Improvement Plan [Member] | Reduction In Global Headcount Positions [Member]
Segment Reporting Information [Line Items]
Severance and other employee-related expenses and transition costs related to restructuring	900,000		4,200,000
2014 Performance Improvement Plan [Member] | Contract Termination [Member]
Segment Reporting Information [Line Items]
License termination costs	4,500,000		4,500,000
Fall 2013 Staff Reduction [Member]
Segment Reporting Information [Line Items]
Severance and other employee-related expenses		1,400,000		3,800,000
Justin Beiber and Nicki Minaj Brand [Member] | 2014 Performance Improvement Plan [Member]
Segment Reporting Information [Line Items]
Asset impairments and related charges	$43,800,000		$43,800,000